<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Blood pressure targets for hypertension in people with diabetes mellitus - Arguedas, JA - 2013 | Cochrane Library</title> <meta content="Blood pressure targets for hypertension in people with diabetes mellitus - Arguedas, JA - 2013 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008277.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Blood pressure targets for hypertension in people with diabetes mellitus - Arguedas, JA - 2013 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008277.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD008277.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Blood pressure targets for hypertension in people with diabetes mellitus" name="citation_title"/> <meta content="Jose Agustin Arguedas" name="citation_author"/> <meta content="Universidad de Costa Rica" name="citation_author_institution"/> <meta content="drarguedas@ampmd.com" name="citation_author_email"/> <meta content="Viriam Leiva" name="citation_author"/> <meta content="University of Costa Rica" name="citation_author_institution"/> <meta content="James M Wright" name="citation_author"/> <meta content="University of British Columbia" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="10" name="citation_issue"/> <meta content="10.1002/14651858.CD008277.pub2" name="citation_doi"/> <meta content="2013" name="citation_date"/> <meta content="2013/10/30" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008277.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008277.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008277.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Blood Pressure; Diabetic Angiopathies [*drug therapy, mortality]; Diastole; Hypertension [*drug therapy, mortality]; Randomized Controlled Trials as Topic; Reference Values; Stroke [prevention &amp; control]; Systole" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008277.pub2&amp;doi=10.1002/14651858.CD008277.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008277.pub2&amp;doi=10.1002/14651858.CD008277.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008277.pub2&amp;doi=10.1002/14651858.CD008277.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008277.pub2&amp;doi=10.1002/14651858.CD008277.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008277.pub2&amp;doi=10.1002/14651858.CD008277.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008277.pub2&amp;doi=10.1002/14651858.CD008277.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008277.pub2&amp;doi=10.1002/14651858.CD008277.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008277.pub2&amp;doi=10.1002/14651858.CD008277.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008277.pub2&amp;doi=10.1002/14651858.CD008277.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008277.pub2&amp;doi=10.1002/14651858.CD008277.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008277.pub2&amp;doi=10.1002/14651858.CD008277.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008277.pub2&amp;doi=10.1002/14651858.CD008277.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008277.pub2&amp;doi=10.1002/14651858.CD008277.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008277.pub2&amp;doi=10.1002/14651858.CD008277.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008277.pub2&amp;doi=10.1002/14651858.CD008277.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008277.pub2&amp;doi=10.1002/14651858.CD008277.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008277.pub2&amp;doi=10.1002/14651858.CD008277.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008277.pub2&amp;doi=10.1002/14651858.CD008277.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008277.pub2&amp;doi=10.1002/14651858.CD008277.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008277.pub2&amp;doi=10.1002/14651858.CD008277.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008277.pub2&amp;doi=10.1002/14651858.CD008277.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008277.pub2&amp;doi=10.1002/14651858.CD008277.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008277.pub2&amp;doi=10.1002/14651858.CD008277.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="zCmos3jT";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD008277\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD008277\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008277\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008277\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ms","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD008277.pub2",title:"Blood pressure targets for hypertension in people with diabetes mellitus",firstPublishedDate:"Oct 30, 2013 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Hypertension Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=zCmos3jT&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008277.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD008277.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD008277.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD008277.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008277.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD008277.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD008277.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD008277.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD008277.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD008277.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>6143 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD008277.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008277.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008277.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008277.pub2/full#CD008277-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008277.pub2/full#CD008277-sec-0060"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008277.pub2/full#CD008277-sec-0015"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008277.pub2/full#CD008277-sec-0016"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008277.pub2/full#CD008277-sec-0021"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008277.pub2/full#CD008277-sec-0024"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008277.pub2/full#CD008277-sec-0042"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008277.pub2/full#CD008277-sec-0054"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008277.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008277.pub2/appendices#CD008277-sec-0065"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008277.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008277.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/table_n/CD008277StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/table_n/CD008277StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008277.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008277.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008277.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD008277.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD008277.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD008277.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2013 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Blood pressure targets for hypertension in people with diabetes mellitus</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008277.pub2/information#CD008277-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Jose Agustin Arguedas</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008277.pub2/information#CD008277-cr-0003">Viriam Leiva</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008277.pub2/information#CD008277-cr-0004">James M Wright</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/information/en#CD008277-sec-0073">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 30 October 2013 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD008277.pub2">https://doi.org/10.1002/14651858.CD008277.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD008277-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD008277-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD008277-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD008277-abs-0006">فارسی</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD008277-abs-0001" lang="en"> <section id="CD008277-sec-0001"> <h3 class="title" id="CD008277-sec-0001">Background</h3> <p>When treating elevated blood pressure (BP), doctors often want to know what blood pressure target they should try to achieve. The standard blood pressure target in clinical practice for some time has been less than 140 ‐ 160/90 ‐ 100 mmHg for the general population of people with elevated blood pressure. Several clinical guidelines published in recent years have recommended lower targets (less than 130/80 mmHg) for people with diabetes mellitus. It is not known whether attempting to achieve targets lower than the standard target reduces mortality and morbidity in those with elevated blood pressure and diabetes. </p> </section> <section id="CD008277-sec-0002"> <h3 class="title" id="CD008277-sec-0002">Objectives</h3> <p>To determine if 'lower' BP targets (any target less than 130/85 mmHg) are associated with reduction in mortality and morbidity compared with 'standard' BP targets (less than 140 ‐ 160/90 ‐ 100 mmHg) in people with diabetes. </p> </section> <section id="CD008277-sec-0003"> <h3 class="title" id="CD008277-sec-0003">Search methods</h3> <p>We searched the Database of Abstracts of Reviews of Effectiveness (DARE) and the Cochrane Database of Systematic Reviews for related reviews. We conducted electronic searches of the Hypertension Group Specialised Register (January 1946 ‐ October 2013), the Cochrane Central Register of Controlled Trials (CENTRAL) (2013, Issue 9), MEDLINE (January 1946 ‐ October 2013), EMBASE (January 1974 ‐ October 2013) and ClinicalTrials.gov. The most recent search was performed on October 4, 2013. </p> <p>Other search sources were the International Clinical Trials Registry Platform (WHO ICTRP), and reference lists of all papers and relevant reviews. </p> </section> <section id="CD008277-sec-0004"> <h3 class="title" id="CD008277-sec-0004">Selection criteria</h3> <p>Randomized controlled trials comparing people with diabetes randomized to lower or to standard BP targets as previously defined, and providing data on any of the primary outcomes below. </p> </section> <section id="CD008277-sec-0005"> <h3 class="title" id="CD008277-sec-0005">Data collection and analysis</h3> <p>Two review authors independently assessed and established the included trials and data entry. Primary outcomes were total mortality; total serious adverse events; myocardial infarction, stroke, congestive heart failure and end‐stage renal disease. Secondary outcomes were achieved mean systolic and diastolic BP, and withdrawals due to adverse effects. </p> </section> <section id="CD008277-sec-0006"> <h3 class="title" id="CD008277-sec-0006">Main results</h3> <p>We found five randomized trials, recruiting a total of 7314 participants and with a mean follow‐up of 4.5 years. Only one trial (ACCORD) compared outcomes associated with 'lower' (&lt; 120 mmHg) or 'standard' (&lt; 140 mmHg) systolic blood pressure targets in 4734 participants. Despite achieving a significantly lower BP (119.3/64.4 mmHg vs 133.5/70.5 mmHg, P &lt; 0.0001), and using more antihypertensive medications, the only significant benefit in the group assigned to 'lower' systolic blood pressure (SBP) was a reduction in the incidence of stroke: risk ratio (RR) 0.58, 95% confidence interval (CI) 0.39 to 0.88, P = 0.009, absolute risk reduction 1.1%. The effect of SBP targets on mortality was compatible with both a reduction and increase in risk: RR 1.05 CI 0.84 to 1.30, low quality evidence. Trying to achieve the 'lower' SBP target was associated with a significant increase in the number of other serious adverse events: RR 2.58, 95% CI 1.70 to 3.91, P &lt; 0.00001, absolute risk increase 2.0%. </p> <p>Four trials (ABCD‐H, ABCD‐N, ABCD‐2V, and a subgroup of HOT) specifically compared clinical outcomes associated with 'lower' versus 'standard' targets for diastolic blood pressure (DBP) in people with diabetes. The total number of participants included in the DBP target analysis was 2580. Participants assigned to 'lower' DBP had a significantly lower achieved BP: 128/76 mmHg vs 135/83 mmHg, P &lt; 0.0001. There was a trend towards reduction in total mortality in the group assigned to the 'lower' DBP target (RR 0.73, 95% CI 0.53 to 1.01), mainly due to a trend to lower non‐cardiovascular mortality. There was no difference in stroke (RR 0.67, 95% CI 0.42 to 1.05), in myocardial infarction (RR 0.95, 95% CI 0.64 to 1.40) or in congestive heart failure (RR 1.06, 95% CI 0.58 to 1.92), low quality evidence. End‐stage renal failure and total serious adverse events were not reported in any of the trials. A sensitivity analysis of trials comparing DBP targets &lt; 80 mmHg (as suggested in clinical guidelines) versus &lt; 90 mmHg showed similar results. There was a high risk of selection bias for every outcome analyzed in favor of the 'lower' target in the trials included for the analysis of DBP targets. </p> </section> <section id="CD008277-sec-0007"> <h3 class="title" id="CD008277-sec-0007">Authors' conclusions</h3> <p>At the present time, evidence from randomized trials does not support blood pressure targets lower than the standard targets in people with elevated blood pressure and diabetes. More randomized controlled trials are needed, with future trials reporting total mortality, total serious adverse events as well as cardiovascular and renal events. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD008277-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD008277-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD008277-abs-0005">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD008277-abs-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ms#CD008277-abs-0004">Bahasa Malaysia</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD008277-abs-0003" lang="en"> <h3>Blood pressure targets in people with diabetes</h3> <p><b>Review Question</b> </p> <p>We conducted this review to find and assess all trials designed to evaluate whether lower blood pressure targets are better than standard blood pressure targets for people with diabetes. We found and analyzed five studies. </p> <p><b>Background</b> </p> <p>Cardiovascular disease is a frequent complication in people with diabetes. Hypertension (high blood pressure) is frequently found in people with diabetes. Recent clinical guidelines have recommended stricter control of blood pressure in people with diabetes compared with those without. For the general population of people with hypertension, the standard target has been to achieve a blood pressure of less than 140 to 160/90 to 100 mmHg, whereas for people with diabetes the guidelines have recommended lowering this target to less than 130/80 mmHg. This trend has been based on the assumption that achieving a lower blood pressure will produce a greater reduction in cardiovascular events. </p> <p><b>Study Characteristics</b> </p> <p>The evidence is current to October 2013. We found and analyzed five randomized trials including 7134 adult participants with type 2 diabetes and high blood pressure, 40‐80 years old, who received treatment aimed to lower blood pressure to a standard compared to a lower blood pressure target and followed for 2 to 5 years to detect differences in mortality and adverse events. Four out of five studies were funded by the drug manufacturer, which had a potential of impacting the results. One study was sponsored by the National Heart, Lung, and Blood Institute (NHLBI) from the United States. </p> <p><b>Key Results</b> </p> <p>The only significant benefit in the group assigned to 'lower' systolic blood pressure was a small reduction in the incidence of stroke, but with a significantly larger increase in the number of other serious adverse events. The effect of systolic blood pressure targets on mortality was compatible with both a reduction and increase in risk. There was no benefit associated with a 'lower' diastolic blood pressure target. </p> <p>The evidence from randomized trials available at the present time is of low quality and does not support blood pressure targets lower than the standard in people with raised blood pressure and diabetes. Further research is likely to change these results and future studies should report all outcomes that are important to patients, such as mortality and adverse events. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD008277-sec-0060" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD008277-sec-0060"></div> <h3 class="title" id="CD008277-sec-0061">Implications for practice</h3> <section id="CD008277-sec-0061"> <p>At the present time the best available evidence from randomized controlled trials (RCTs) does not support blood pressure (BP) targets lower than 140/90 mmHg in people with elevated blood pressure and diabetes. This review analyzed lower systolic and diastolic blood pressure (SBP, DBP) targets separately, with similar findings for both targets. The isolated small reduction in stroke associated with a lower SBP target must be weighed against a larger increase in serious adverse events. </p> <p>Therefore, the lower target for blood pressure recommended for people with diabetes in many clinical guidelines is not supported by evidence from randomized controlled trials. </p> </section> <h3 class="title" id="CD008277-sec-0062">Implications for research</h3> <section id="CD008277-sec-0062"> <p>This review provides strong support for the need for independently‐conducted RCTs evaluating lower BP targets in the population of people with diabetes mellitus. The absence of information in people with type 1 diabetes is particularly regrettable. Future trials should report total mortality and total serious adverse events as well as individual cardiovascular, cerebrovascular and renal events. Other outcomes such as health‐related quality of life should also be investigated.  </p> <p>Finally, future research must evaluate whether trying to achieve a BP target is better than alternative therapeutic strategies, such as a fixed‐dose strategy. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD008277-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD008277-sec-0015"></div> <div class="table" id="CD008277-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span><span class="table-title"></span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Lower blood pressure (BP) targets compared with standard BP targets for mortality and morbidity</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population: Diabetes Mellitus</b> with elevated blood pressure </p> <p><b>Settings: outpatients</b> </p> <p><b>Intervention: BP &lt; 130/85 mmHg</b> </p> <p><b>Comparison: BP &lt; 140 ‐ 160/90 ‐ 100 mmHg</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Standard BP targets</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Lower BP targets</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Total mortality</b> </p> <p>Systolic targets</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 1.05</b> (0.84 to 1.30) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>4734<br/> (1) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low<sup>4</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>Only one RCT</p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Medium risk population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>60 per 1000<sup>1</sup> </b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>63 per 1000</b> <br/> (50 to 78) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Total mortality</b> </p> <p>Diastolic targets</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Low risk population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 0.73</b> (0.53 to 1.01) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>2580<br/> (4) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low<sup>5</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>High risk of bias</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>30 per 1000<sup>2</sup> </b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>22 per 1000</b> <br/> (16 to 30) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Medium risk population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>60 per 1000<sup>1</sup> </b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>44 per 1000</b> <br/> (32 to 61) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High risk population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>100 per 1000<sup>3</sup> </b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>73 per 1000</b> <br/> (53 to 101) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Total serious adverse events</b> </p> <p>Systolic targets</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 1.01</b> (0.91 to 1.13) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>4734<br/> (1) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low<sup>6</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>Only one RCT</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Medium risk population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>214 per 1000<sup>1</sup> </b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>216 per 1000</b> <br/> (197 to 244) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Based on the event rate in the standard BP target group.<br/> <sup>2</sup>One‐half the medium event rate.<br/> <sup>3</sup>Medium event rate times 1.7.<br/> <sup>4</sup>Only one RCT and confidence intervals includes a 25% increase.<br/> <sup>5</sup>Inadequate sequence generation, no blinding, subgroup analysis and early termination.<br/> <sup>6</sup>Only one RCT and no blinding. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD008277-sec-0016" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD008277-sec-0016"></div> <section id="CD008277-sec-0017"> <h3 class="title" id="CD008277-sec-0017">Description of the condition</h3> <p>Epidemiological studies show a continuous direct relationship between adverse cardiovascular events and blood pressure (BP), with elevated blood pressure defined as one of the major risk factors for adverse cardiovascular events (<a href="./references#CD008277-bbs2-0039" title="MacMahonS , PetoR , CutlerJ , CollinsR , SorlieP , NeatonJ , et al. Blood pressure, stroke and CHD. Part 1. Prolonged differences in blood pressure: prospective observational studies collected for the regression dilution blas. Lancet1990;335(8692):765‐74. ">MacMahon 1990</a>; <a href="./references#CD008277-bbs2-0050" title="StamlerJ , StamlerR , NeatonJD . Blood Pressure, systolic and diastolic and cardiovascular risk. US population data. Archives of Internal Medicine1993;153(5):598‐615. ">Stamler 1993</a>; <a href="./references#CD008277-bbs2-0036" title="KannelWB . Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA1996;275(20):1571‐6. ">Kannel 1996</a>; <a href="./references#CD008277-bbs2-0046" title="LewingtonS , ClarkeR , QisilbashN , PetoR , CollinsR , Prospective Studies Collaboration. Age‐specific relevance of usual blood pressure to vascular mortality: a meta‐analysis of individual data for one million adults in 61 prospective studies. Lancet2002;360(9349):1903‐13. ">Prospective Studies 2002</a>). The primary goal in the management of people with elevated blood pressure (hypertension) is to maximize the reduction in mortality and morbidity (<a href="./references#CD008277-bbs2-0044" title="OparilS , ZamanMA , CalhounDA . Pathogenesis of hypertension. Annals of Internal Medicine2003;139(9):761‐76. ">Oparil 2003</a>; <a href="./references#CD008277-bbs2-0028" title="ManciaG , DeBackerG , DomiiczakA , CifkovaR , FagardR , GermanoG , et al. 2007 Guidelines for the management of arterial hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Journal of Hypertension2007;25(6):1105‐87. ">ESH‐ESC 2007</a>). The lower threshold at which this relationship no longer applies has not been definitively identified (<a href="./references#CD008277-bbs2-0046" title="LewingtonS , ClarkeR , QisilbashN , PetoR , CollinsR , Prospective Studies Collaboration. Age‐specific relevance of usual blood pressure to vascular mortality: a meta‐analysis of individual data for one million adults in 61 prospective studies. Lancet2002;360(9349):1903‐13. ">Prospective Studies 2002</a>). </p> <p>Any numerical cut‐off value above which elevated blood pressure is defined is arbitrary. The standard for diagnosis of arterial hypertension is based on consensus recommendations, which attempt to predict the blood pressure above which it is expected that treatment will provide more benefit than harm. </p> <p>Recent guidelines in Europe acknowledge the paucity of evidence related to the benefit from drugs in mild hypertension. The same limitation applies to BP targets to be reached on treatment: the benefit from drug treatment seems rather clear with treatments aiming at lowering BP levels at less than 160 for systolic or 100 mmHg for diastolic, whereas no data are available for promoting lower targets. This statement is based 1) on the targets adopted in trials that showed the benefit from drugs in primary prevention in hypertensive people without other conditions, and 2) on the analysis of the part of risk reduction due to treatment that could be attributed to BP lowering. This part has been estimated to be about 60% for stroke (<a href="./references#CD008277-bbs2-0022" title="BoisselJP , GueyffierF , BoutitieF , PocockS , FagardR . Apparent effect on blood pressure is only partly responsible for the risk reduction due to antihypertensive treatments. Fundamental &amp; Clinical Pharmacology2005;19(5):579‐84. ">Boissel 2005</a>). Of note, the benefit from some BP‐lowering drugs has been established in other conditions with normal or even low BP levels, e.g. congestive heart failure, secondary prevention after stroke or myocardial infarction, high cardiovascular risk. In these situations, the benefit from these drugs has been established with fixed dosages, without any adjustment to the apparent BP level or response. The superiority of a strategy guided by a predefined BP target has not proved superior to a fixed‐dosage strategy. </p> <p>Diastolic blood pressure was privileged for the inclusion criteria or the treatment target in the first trials conducted with antihypertensive drugs, during the last three decades of the previous century. Systolic BP has been used more recently, initially to explore whether isolated systolic hypertension frequently observed after 60 years of age was associated with a benefit from these drugs, and subsequently for two reasons: its prognostic value appeared greater than that of diastolic BP, and it is observable in all age ranges, whereas the value of diastolic BP was observable in young people and disappeared or even reverted in older people. </p> <p>Diabetes is also identified as one of the major risk factors for adverse cardiovascular (CV) events, and CV complications are the most frequent reason for mortality in people with diabetes (<a href="./references#CD008277-bbs2-0051" title="StamlerJ , VaccaroO , NeatonJD , WentworthD . Diabetes, other risk factors, and 12‐yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care1993;16:434‐44. ">Stamler 1993b</a>). Furthermore, arterial hypertension is frequently detected in people with diabetes mellitus, possibly hastening the development and progression of complications (<a href="./references#CD008277-bbs2-0015" title="AdlerAI , StrattonIM , NeilHA , YudkinJS , MatthewsCR , CullCA , et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ2000;321(7258):412‐9. ">Adler 2000</a>). At the present time the threshold above which antihypertensive treatment benefits outweigh harm in people with diabetes remains unclear. </p> </section> <section id="CD008277-sec-0018"> <h3 class="title" id="CD008277-sec-0018">Description of the intervention</h3> <p>The target blood pressure is used in clinical practice as the goal of antihypertensive therapy. It guides the clinical practitioner when making treatment decisions related to the intensity of the antihypertensive regimen used for each patient. </p> </section> <section id="CD008277-sec-0019"> <h3 class="title" id="CD008277-sec-0019">How the intervention might work</h3> <p>Blood pressure targets lower than standard have become more prevalent in recent guidelines and thus in clinical practice. This trend toward 'the lower the pressure the better' was expressed in an editorial accompanying the publication of the 2004 British Hypertension Society guidelines (<a href="./references#CD008277-bbs2-0038" title="LaurentS . Guidelines from the British Hypertension Society.  The lower the pressure the better. BMJ2004;328(7440):593‐4. ">Laurent 2004</a>), and assumes that treatment to lower blood pressure targets with antihypertensive drugs will achieve the predicted reduction in cardiovascular morbidity and mortality seen in epidemiological observational studies. This trend has been especially strong for people with diabetes mellitus and those with chronic renal disease, for whom even lower targets have been promoted based on the assumption that they have a higher cardiovascular risk. </p> </section> <section id="CD008277-sec-0020"> <h3 class="title" id="CD008277-sec-0020">Why it is important to do this review</h3> <p>The importance of this review is emphasized by the blood pressure targets recommended for people with diabetes mellitus in several clinical guidelines published in recent years (<a href="./references#CD008277-bbs2-0035" title="ChobanianAV , BakrisGL , BlackHR , CushmanWC , GreenLA , IzzoJLJr , et al. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.  The JNC 7 report. JAMA2003;289(19):2560‐72. ">JNC 7 2003</a>; <a href="./references#CD008277-bbs2-0053" title="WhitworthJA , World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO/International Society of Hypertension (ISH) statement on management of hypertension. Journal of Hypertension2003;21(11):1983‐92. ">WHO/ISH 2003</a>; <a href="./references#CD008277-bbs2-0021" title="WilliamsB , PoulterNR , BrownMJ , DavisM , McInnesGT , PotterJF , et al. British Hypertension Society guidelines for hypertension management 2004 (BHS‐IV): summary. BMJ2004;328(7440):634‐40. ">BHS 2004</a>; <a href="./references#CD008277-bbs2-0016" title="RosendorffC , BlackHR , CannonCP , GershBJ , GoreJ , IzzoJLJr , et al. Treatment of hypertension in the prevention and management of ischemic heart disease. A scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation2007;115(21):2761‐88. ">AHA 2007</a>; <a href="./references#CD008277-bbs2-0028" title="ManciaG , DeBackerG , DomiiczakA , CifkovaR , FagardR , GermanoG , et al. 2007 Guidelines for the management of arterial hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Journal of Hypertension2007;25(6):1105‐87. ">ESH‐ESC 2007</a>; <a href="./references#CD008277-bbs2-0037" title="SánchezRA , AyalaM , BaglivoH , et al. Latin American Expert Group. Latin American Guidelines on Hypertension. J Hypertens2009;27:905‐22. ">LA 2009</a>; <a href="./references#CD008277-bbs2-0024" title="RabiDM , DaskalopoulouSS , PadwalRS , KhanNA , GroverSA , HackamDG , et al. The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. Canadian Journal of Cardiology2011;27(4):415‐33. ">CHEP 2011</a>; <a href="./references#CD008277-bbs2-0013" title="American Diabetes Association. Standards of medical care in diabetes. Diabetes Care2012;35(Suppl 1):S11‐63. ">ADA 2012</a>). These guidelines recommend a BP target lower than 130/80 mmHg in people with diabetes, mainly based on observational data and on retrospective analyses of outcome trials. Most of these guidelines also recommend initiating antihypertensive drug treatment in people with diabetes with systolic blood pressure (SBP) higher than 130 mmHg or diastolic blood pressure (DBP) higher than 80 to 85 mmHg.       </p> <p>However, elevated blood pressure can be considered as a marker of vascular disease, and an aggressive reduction in blood pressure does not necessarily mean that the pathological and functional vascular abnormalities already established will be reversed. </p> <p>Attempting to achieve lower blood pressure targets has several consequences. The most obvious is the need for large doses or an increased number of antihypertensive drugs. This has costs to patients in terms of inconvenience and economic burdens. More drugs and higher doses will also increase adverse drug effects, which if serious could cancel any potential benefit associated with any lower blood pressures achieved. In addition, there is the potential that lowering blood pressure too much with drugs can cause adverse cardiovascular events, such as the so‐called 'J‐curve phenomenon', mentioned for many years in medical articles and revisited in recent years, especially in the elderly or in people with established coronary disease (<a href="./references#CD008277-bbs2-0030" title="FarnettL , MulrowCD , LinnWD , LuceyCR , TuleyMR . The J‐curve phenomenon and the treatment of hypertension. Is there a point beyond which pressure reduction is dangerous?. JAMA1991;265(4):489‐95. ">Farnett 1991</a>; <a href="./references#CD008277-bbs2-0052" title="VokóZ , BotsML , HofmanA , KoudstaalPJ , WittemanJC , BretelerMM . J‐shaped relation between blood pressure and stroke in treated hypertensives. Hypertension1999;34(6):1181‐7. ">Vokó 1999</a>; <a href="./references#CD008277-bbs2-0054" title="ZanchettiA , HanssonL , ClementD , ElmfeldtD , JuliusS , RosenthalT , et al. HOT Study Group. Benefits and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk‐profiles: does a J‐shaped curve exist in smokers?. Journal of Hypertension2003;21(4):797‐804. ">Zanchetti 2003</a>; <a href="./references#CD008277-bbs2-0042" title="MesserliFH , ManciaG , ContiCR , HewkinAC , KupferS , ChampionA , et al. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?. Annals of Internal Medicine2006;144(12):884‐93. ">Messerli 2006</a>; <a href="./references#CD008277-bbs2-0049" title="SleightP , RedonJ , VerdecchiaP , ManciaG , GaoP , FagardR , et al. Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial study. Journal of Hypertension2009;27(7):1360‐9. ">Sleight 2009</a>; <a href="./references#CD008277-bbs2-0019" title="BangaloreS , MesserliFH , WunCC , ZuckermanAL , DeMiccoD , KostisJB , et al. J‐curve revisited: an analysis of blood pressure and cardiovascular events in the Treating to  New Targets (TNT) Trial. European Heart Journal2010;31(23):2897‐908. ">Bangalore 2010</a>; <a href="./references#CD008277-bbs2-0027" title="DorresteijnJA , Van derGraafY , SpieringW , GrobbeeDE , BotsML , VisserenFL , Secondary Manifestations of Arterial Disease Study Group. Relation between blood pressure and vascular events and mortality in patients with manifest vascular disease.  J‐curve revisited. Hypertension2012;59(1):14‐21. ">Dorresteijn 2012</a>). </p> <p>The only way to prove that a lower BP target is beneficial is through clinical trials where participants are randomized to different treatment targets. In that respect, in a previous Cochrane systematic review and meta‐analysis of randomized controlled clinical trials (<a href="./references#CD008277-bbs2-0017" title="ArguedasJA , PerezMI , WrightJM . Treatment blood pressure targets for hypertension. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD004349.pub2] ">Arguedas 2009</a>), we showed that, in the general population of people with hypertension, treating to blood pressure targets lower than 130/85 mmHg by pharmacological means did not result in lower mortality or cardiovascular morbidity compared with standard targets (lower than 140 ‐ 160 mmHg systolic and lower than 90 ‐ 100 mmHg diastolic). In the same Cochrane review, a sensitivity analysis in people with diabetes did not provide sufficient evidence for recommending lower blood pressure targets in that patient population. Therefore, the assumption that treating to lower targets would provide a greater reduction in cardiovascular risk, as suggested by epidemiological studies, was not proven, and 'the lower the better' strategy in hypertension was challenged (<a href="./references#CD008277-bbs2-0018" title="ArguedasJA . Blood pressure targets: are clinical guidelines wrong?. Current Opinion in Cardiology2010;25(4):350‐4. ">Arguedas 2010</a>; <a href="./references#CD008277-bbs2-0031" title="FilipponeEJ , FoyA , NewmanE . Goal‐directed antihypertensive therapy: lower may not always be better. Cleveland Clinic Journal of Medicine2011;78(2):123‐33. ">Filippone 2011</a>; <a href="./references#CD008277-bbs2-0032" title="GrossmanE . Blood pressure: the lower, the better.  The con side. Diabetes Care2011;34(Suppl 2):308‐12. ">Grossman 2011</a>). A recent observational analysis did not show any difference in cardiovascular outcomes between SBP less than 130 mmHg and less than 140 mmHg in people with diabetes and coronary disease (<a href="./references#CD008277-bbs2-0025" title="Cooper‐DeHoffRM , GongY , HandbergEM , BavryAA , DenardoSJ , BakrisGL , et al. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA2010;304(1):61‐8. ">Cooper‐DeHoff 2010</a>). </p> <p>A more recent clinical guideline, published by the National Institute for Health and Clinical Excellence (NICE) and the British Hypertension Society (<a href="./references#CD008277-bbs2-0043" title="National Institute for Health and Clinical Excellence. Hypertension.  Clinical management of primary hypertension in adults. NICE clinical guideline 1272011:1‐36. ">NICE 2011</a>) states “aim for a target clinic blood pressure below 140/90 mmHg in people aged under 80 years with treated hypertension” without providing any different criteria for people with diabetes. The latest American Diabetes Association clinical guideline recommends that people with diabetes and hypertension should be treated to a systolic blood pressure goal of less than 140 mmHg, and to a diastolic blood pressure goal of less than 80 mmHg (<a href="./references#CD008277-bbs2-0014" title="American Diabetes Association. Standards of medical care in diabetes 2013. Diabetes Care2013;36(Suppl 1):S11‐66. ">ADA 2013</a>). Finally, the most recently published European guideline (<a href="./references#CD008277-bbs2-0029" title="ManciaG , FagardR , NarkiewiczK , RedonJ , ZanchettiA , BöhmM , et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). European Heart Journal2013;34(28):2159‐219. ">ESH/ESC2013</a>) recommends a target lower than 140/85 mmHg for people with diabetes. </p> <p>Given that many clinical guidelines are still recommending lower blood pressure targets for people with diabetes, our goal was to identify all randomized controlled trials where people with diabetes were randomized to lower targets (less than 130/85 mmHg) compared with the standard targets. Standard targets were defined as a systolic blood pressure target less than or equal to 140 ‐ 160 mmHg, and a diastolic blood pressure target less than or equal to 90 ‐ 100 mmHg. We have chosen a range for both standard target categories to be inclusive and to make sure that the two treatment groups are mutually exclusive. Treatment targets higher than those previously mentioned were not eligible because they were considered to be inappropriately high.  </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD008277-sec-0021" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD008277-sec-0021"></div> <section id="CD008277-sec-0022"> <h3 class="title" id="CD008277-sec-0022">Primary objective</h3> <p>To determine if 'lower' BP targets (any target less than 130/85 mmHg) are associated with reduction in mortality and morbidity compared with 'standard' BP targets (less than 140 ‐ 160/90 ‐ 100 mmHg) in people with diabetes. </p> </section> <section id="CD008277-sec-0023"> <h3 class="title" id="CD008277-sec-0023">Secondary objectives</h3> <p> <ol id="CD008277-list-0001"> <li> <p>To determine if there is a change in mean achieved systolic and diastolic blood pressure associated with 'lower targets' compared with 'standard targets' in people with diabetes and elevated blood pressure.   </p> </li> <li> <p>To determine if there is a change in withdrawals due to adverse effects with 'lower targets' compared with 'standard targets', in people with diabetes and elevated blood pressure.  </p> </li> </ol> </p> </section> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD008277-sec-0024" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD008277-sec-0024"></div> <section id="CD008277-sec-0025"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD008277-sec-0026"> <h4 class="title">Types of studies</h4> <p>We considered only randomized controlled clinical trials. Trials cannot be blinded to blood pressure targets because the treating physicians must know the target to which each participant has been assigned in order to make the proper adjustment in the therapy to achieve the blood pressure goal.  </p> <p>All trials that reported any of the outcomes were included. Trials were not limited by any concomitant disease, other factor or baseline cardiovascular risk. There was no language restriction. </p> </section> <section id="CD008277-sec-0027"> <h4 class="title">Types of participants</h4> <p>Participants were adults with diabetes mellitus and elevated blood pressure, documented in a standard way on at least two occasions, or already receiving treatment for elevated blood pressure.  </p> <p>Since any numerical definition of elevated blood pressure is arbitrary, we included trials if people with diabetes were randomized to one of the two targets described below, irrespective of their baseline blood pressure.    </p> </section> <section id="CD008277-sec-0028"> <h4 class="title">Types of interventions</h4> <p>We included trials if individuals were randomized to a 'lower' compared with a 'standard' target blood pressure as defined above. </p> </section> <section id="CD008277-sec-0029"> <h4 class="title">Types of outcome measures</h4> <section id="CD008277-sec-0030"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD008277-list-0002"> <li> <p>All‐cause mortality plus cardiovascular and non‐cardiovascular mortality separately.</p> </li> <li> <p>Total serious adverse events (total serious morbidity and mortality).</p> </li> <li> <p>Cardiovascular serious adverse events, including myocardial infarction, stroke, congestive heart failure, end‐stage renal failure. </p> </li> <li> <p>All other serious adverse events.</p> </li> </ol> </p> </section> <section id="CD008277-sec-0031"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD008277-list-0003"> <li> <p>Systolic blood pressure achieved.</p> </li> <li> <p>Diastolic blood pressure achieved.</p> </li> <li> <p>Withdrawals due to adverse effects.</p> </li> <li> <p>Number of antihypertensive drugs needed per participant.</p> </li> </ol> </p> </section> </section> </section> <section id="CD008277-sec-0032"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD008277-sec-0033"> <h4 class="title">Electronic searches</h4> <p>We searched the Database of Abstracts of Reviews of Effectiveness (DARE) and the Cochrane Database of Systematic Reviews for related reviews. </p> <p>We searched the following electronic databases for primary studies: the Hypertension Group Specialised Register (January 1946 ‐ October 2013), the Cochrane Central Register of Controlled Trials (CENTRAL) (2013, Issue 9), MEDLINE (January 1946 ‐ October 2013), EMBASE (January 1974 ‐ October 2013) and ClinicalTrials.gov. </p> <p>We searched the electronic databases using a strategy combining the Cochrane Highly Sensitive Search Strategy for identifying randomized trials in MEDLINE: sensitivity‐ and precision‐maximizing version (2008 revision) with selected MeSH terms and free‐text terms relating to diabetes and hypertension. We applied no language restrictions. The MEDLINE search strategy (<a href="./appendices#CD008277-sec-0066">Appendix 1</a>) was translated into EMBASE (<a href="./appendices#CD008277-sec-0067">Appendix 2</a>), CENTRAL (<a href="./appendices#CD008277-sec-0068">Appendix 3</a>), The Hypertension Group Specialised Register (<a href="./appendices#CD008277-sec-0069">Appendix 4</a>), and ClinicalTrials.gov (<a href="./appendices#CD008277-sec-0070">Appendix 5</a>) using the appropriate controlled vocabulary as applicable. The latest search date for all databases was October 2013. </p> </section> <section id="CD008277-sec-0034"> <h4 class="title">Searching other resources</h4> <p>Other sources:<br/> a)  International Clinical Trials Registry Platform (WHO ICTRP);<br/> b)  Reference lists of all papers and relevant reviews identified;<br/> c)  We tried to contact authors of relevant papers regarding any further published or unpublished work;<br/> d)  We tried to contact authors of trials reporting incomplete information to provide the missing information;<br/> e)  We searched ISI Web of Science for papers which cite studies included in the review. </p> </section> </section> <section id="CD008277-sec-0035"> <h3 class="title" id="CD008277-sec-0035">Data collection and analysis</h3> <section id="CD008277-sec-0036"> <h4 class="title">Selection of studies</h4> <p>We prespecified the outcomes to be compared and the trial eligibility criteria before the result of any contributing trial was known. Two independent review authors assessed the eligibility of the trials, resolving discrepancies by discussion or by recourse to a third individual if necessary. </p> </section> <section id="CD008277-sec-0037"> <h4 class="title">Data extraction and management</h4> <p>Two review authors independently extracted data from the included trials. For the synthesis and analysis of the data, we used Cochrane Review Manager software (<a href="./references#CD008277-bbs2-0048" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">RevMan 2012</a>). Quantitative analyses of outcomes were based on an intention‐to‐treat principle.  </p> </section> <section id="CD008277-sec-0038"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors independently performed the assessment of risk of bias for each study, using the six domains of the 'Risk of bias' Tool according to the method described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD008277-bbs2-0034" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> </section> <section id="CD008277-sec-0039"> <h4 class="title">Measures of treatment effect</h4> <p>We used the risk ratio (RR) and a fixed‐effect model to combine outcomes across trials.</p> </section> <section id="CD008277-sec-0040"> <h4 class="title">Dealing with missing data</h4> <p>We tried to contact authors in case of missing information in the retrieved articles.</p> </section> <section id="CD008277-sec-0041"> <h4 class="title">Assessment of heterogeneity</h4> <p>We used the Chi² and I² statistics to test for heterogeneity of treatment effect between the trials (<a href="./references#CD008277-bbs2-0033" title="HigginsJPT , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327(7414):557‐60. ">Higgins 2003</a>). A Chi² value less than 0.05 or an I² value greater than 50% was considered indicative of significant heterogeneity. We planned to use a random‐effects model to test for statistical significance if significant heterogeneity existed.  </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD008277-sec-0042" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD008277-sec-0042"></div> <section id="CD008277-sec-0043"> <h3 class="title">Description of studies</h3> <section id="CD008277-sec-0044"> <h4 class="title">Results of the search</h4> <p>The search identified 597 records. There remained 235 publications after partial screen and removal of duplicates by Trials Research Coordinator. Most of those publications were rejected after reading the abstract or the complete report. This left 11 references that seemed appropriate for this systematic review (<a href="#CD008277-fig-0001">Figure 1</a>). The detailed analysis of those 11 publications revealed: </p> <div class="figure" id="CD008277-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Results of the search." data-id="CD008277-fig-0001" src="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_n/nCD008277-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Results of the search.</p> </div> </div> </div> <p>‐ 5 randomized controlled trials from 6 publications that met the inclusion criteria</p> <p>‐ 5 randomized controlled trials that did not meet the inclusion criteria</p> </section> <section id="CD008277-sec-0045"> <h4 class="title">Included studies</h4> <p>One trial (<a href="./references#CD008277-bbs2-0004" title="The ACCORD Study Group. Effects of intensive blood‐pressure control in type 2 diabetes mellitus. New England Journal of Medicine2010;362(17):1575‐85. ">ACCORD BP 2010</a>) compared clinical outcomes associated with different systolic blood pressure (SBP) targets within our definitions for ‘lower’ and ‘standard’ targets. Four trials (<a href="./references#CD008277-bbs2-0002" title="EstacioRO , JeffersBW , HiattWR , BiggerstaffSl , GiffordN , SchrierRW . The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non‐insulin‐dependent diabetes and hypertension. New England Journal of Medicine1998;338(10):645‐52. ">ABCD‐H 1998</a>, <a href="./references#CD008277-bbs2-0003" title="SchrierRW , EstacioRO , EslerA , MehlerP . Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney International2002;61(3):1086‐97. ">ABCD‐N 2002</a>, <a href="./references#CD008277-bbs2-0001" title="EstacioRO , CollJR , TranZV , SchrierRW . Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes. American Journal of Hypertension2006;19(12):1241‐8. ">ABCD‐2V 2006</a>, and the subgroup of people with diabetes in <a href="./references#CD008277-bbs2-0005" title="HanssonL , ZanchettiA , CarruthersSG , DahlöfB , ElmfeldtB , JuliusS , et al. Effects of intensive blood‐pressure lowering and low‐dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. HOT Stdy Group. Lancet1998;351(9118):1755‐62. ">HOT 1998</a>) compared clinical outcomes associated with different diastolic blood pressure (DBP) targets meeting our definitions for ‘lower’ and ‘standard’ targets </p> <p>a. Methods:</p> <p>The 5 included trials were randomized and open label. In each trial an independent end point committee, which was blinded to the study intervention arms, reviewed all cardiovascular events. </p> <p>In <a href="./references#CD008277-bbs2-0004" title="The ACCORD Study Group. Effects of intensive blood‐pressure control in type 2 diabetes mellitus. New England Journal of Medicine2010;362(17):1575‐85. ">ACCORD BP 2010</a> the participants were also randomly assigned (in a 2‐by‐2 factorial design) to either intensive or standard glycemic control (the ACCORD glycemia trial). In <a href="./references#CD008277-bbs2-0005" title="HanssonL , ZanchettiA , CarruthersSG , DahlöfB , ElmfeldtB , JuliusS , et al. Effects of intensive blood‐pressure lowering and low‐dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. HOT Stdy Group. Lancet1998;351(9118):1755‐62. ">HOT 1998</a> the participants were also randomly assigned in a factorial design to receive aspirin or placebo. </p> <p>The follow‐up period varied from 1.9 to 5 years.</p> <p><a href="./references#CD008277-bbs2-0004" title="The ACCORD Study Group. Effects of intensive blood‐pressure control in type 2 diabetes mellitus. New England Journal of Medicine2010;362(17):1575‐85. ">ACCORD BP 2010</a> was conducted in the United States and Canada. <a href="./references#CD008277-bbs2-0005" title="HanssonL , ZanchettiA , CarruthersSG , DahlöfB , ElmfeldtB , JuliusS , et al. Effects of intensive blood‐pressure lowering and low‐dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. HOT Stdy Group. Lancet1998;351(9118):1755‐62. ">HOT 1998</a> included participants from 26 countries from Europe, Asia, North and South America. </p> <p>b. Participants:</p> <p>The inclusion criteria varied among the trials (see table of characteristics of included studies). <a href="./references#CD008277-bbs2-0004" title="The ACCORD Study Group. Effects of intensive blood‐pressure control in type 2 diabetes mellitus. New England Journal of Medicine2010;362(17):1575‐85. ">ACCORD BP 2010</a>, <a href="./references#CD008277-bbs2-0002" title="EstacioRO , JeffersBW , HiattWR , BiggerstaffSl , GiffordN , SchrierRW . The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non‐insulin‐dependent diabetes and hypertension. New England Journal of Medicine1998;338(10):645‐52. ">ABCD‐H 1998</a>, <a href="./references#CD008277-bbs2-0003" title="SchrierRW , EstacioRO , EslerA , MehlerP . Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney International2002;61(3):1086‐97. ">ABCD‐N 2002</a>, and <a href="./references#CD008277-bbs2-0001" title="EstacioRO , CollJR , TranZV , SchrierRW . Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes. American Journal of Hypertension2006;19(12):1241‐8. ">ABCD‐2V 2006</a> only included people with type 2 diabetes. The type of diabetes was not specified in <a href="./references#CD008277-bbs2-0005" title="HanssonL , ZanchettiA , CarruthersSG , DahlöfB , ElmfeldtB , JuliusS , et al. Effects of intensive blood‐pressure lowering and low‐dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. HOT Stdy Group. Lancet1998;351(9118):1755‐62. ">HOT 1998</a>. <a href="./references#CD008277-bbs2-0004" title="The ACCORD Study Group. Effects of intensive blood‐pressure control in type 2 diabetes mellitus. New England Journal of Medicine2010;362(17):1575‐85. ">ACCORD BP 2010</a> also required a high cardiovascular risk, defined by already established cardiovascular disease, evidence of subclinical cardiovascular disease, or at least two additional risk factors for cardiovascular disease. </p> <p>The baseline blood pressure required for inclusion also varied. <a href="./references#CD008277-bbs2-0004" title="The ACCORD Study Group. Effects of intensive blood‐pressure control in type 2 diabetes mellitus. New England Journal of Medicine2010;362(17):1575‐85. ">ACCORD BP 2010</a> required a systolic blood pressure between 130 and 180 mmHg when taking three or fewer antihypertensive medications to be included. Participants in <a href="./references#CD008277-bbs2-0002" title="EstacioRO , JeffersBW , HiattWR , BiggerstaffSl , GiffordN , SchrierRW . The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non‐insulin‐dependent diabetes and hypertension. New England Journal of Medicine1998;338(10):645‐52. ">ABCD‐H 1998</a> had a baseline diastolic blood pressure equal to or higher than 90 mm Hg. Participants in <a href="./references#CD008277-bbs2-0003" title="SchrierRW , EstacioRO , EslerA , MehlerP . Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney International2002;61(3):1086‐97. ">ABCD‐N 2002</a> had a baseline diastolic blood pressure between 80 and 89 mmHg and were not receiving antihypertensive medications at the randomization visit, but some of them had elevated systolic blood pressure. <a href="./references#CD008277-bbs2-0001" title="EstacioRO , CollJR , TranZV , SchrierRW . Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes. American Journal of Hypertension2006;19(12):1241‐8. ">ABCD‐2V 2006</a> included people with a systolic BP lower than 140 mmHg, and a diastolic BP between 80 and 90 mmHg. In <a href="./references#CD008277-bbs2-0005" title="HanssonL , ZanchettiA , CarruthersSG , DahlöfB , ElmfeldtB , JuliusS , et al. Effects of intensive blood‐pressure lowering and low‐dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. HOT Stdy Group. Lancet1998;351(9118):1755‐62. ">HOT 1998</a> the baseline diastolic blood pressure was between 100 mmHg and 115 mmHg. </p> <p>The trials included people between the ages of 40 and 81 years. The number of participants included in each study was: <a href="./references#CD008277-bbs2-0001" title="EstacioRO , CollJR , TranZV , SchrierRW . Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes. American Journal of Hypertension2006;19(12):1241‐8. ">ABCD‐2V 2006</a>: 129 participants; <a href="./references#CD008277-bbs2-0002" title="EstacioRO , JeffersBW , HiattWR , BiggerstaffSl , GiffordN , SchrierRW . The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non‐insulin‐dependent diabetes and hypertension. New England Journal of Medicine1998;338(10):645‐52. ">ABCD‐H 1998</a>: 470 participants; <a href="./references#CD008277-bbs2-0003" title="SchrierRW , EstacioRO , EslerA , MehlerP . Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney International2002;61(3):1086‐97. ">ABCD‐N 2002</a>: 480 participants; <a href="./references#CD008277-bbs2-0004" title="The ACCORD Study Group. Effects of intensive blood‐pressure control in type 2 diabetes mellitus. New England Journal of Medicine2010;362(17):1575‐85. ">ACCORD BP 2010</a>: 4733 participants; <a href="./references#CD008277-bbs2-0005" title="HanssonL , ZanchettiA , CarruthersSG , DahlöfB , ElmfeldtB , JuliusS , et al. Effects of intensive blood‐pressure lowering and low‐dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. HOT Stdy Group. Lancet1998;351(9118):1755‐62. ">HOT 1998</a>: 1501 participants. </p> <p>c. Interventions:</p> <p>Participants in <a href="./references#CD008277-bbs2-0004" title="The ACCORD Study Group. Effects of intensive blood‐pressure control in type 2 diabetes mellitus. New England Journal of Medicine2010;362(17):1575‐85. ">ACCORD BP 2010</a> were randomly assigned to intensive therapy that targeted systolic blood pressure of less than 120 mmHg, or standard therapy that targeted systolic blood pressure of less than 140 mmHg. </p> <p>Participants in <a href="./references#CD008277-bbs2-0002" title="EstacioRO , JeffersBW , HiattWR , BiggerstaffSl , GiffordN , SchrierRW . The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non‐insulin‐dependent diabetes and hypertension. New England Journal of Medicine1998;338(10):645‐52. ">ABCD‐H 1998</a> and <a href="./references#CD008277-bbs2-0001" title="EstacioRO , CollJR , TranZV , SchrierRW . Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes. American Journal of Hypertension2006;19(12):1241‐8. ">ABCD‐2V 2006</a> were randomized into two treatment arms consisting of ‘intensive’ treatment with a diastolic blood pressure goal of 75 mmHg, and ‘moderate’ treatment with a diastolic blood pressure goal of 80‐89 mmHg. </p> <p>Participants in <a href="./references#CD008277-bbs2-0003" title="SchrierRW , EstacioRO , EslerA , MehlerP . Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney International2002;61(3):1086‐97. ">ABCD‐N 2002</a> were randomized into two treatment arms consisting of "intensive" or "moderate" treatment. The goal in the "intensive" treatment group was to achieve a decrease of 10 mmHg below baseline in diastolic blood pressure (i.e. 70 to 79 mmHg), whereas the goal in the "moderate" treatment group was to maintain a diastolic blood pressure between 80 and 89 mmHg. </p> <p>Participants in <a href="./references#CD008277-bbs2-0005" title="HanssonL , ZanchettiA , CarruthersSG , DahlöfB , ElmfeldtB , JuliusS , et al. Effects of intensive blood‐pressure lowering and low‐dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. HOT Stdy Group. Lancet1998;351(9118):1755‐62. ">HOT 1998</a> were randomly assigned to one of three diastolic blood pressure target groups: less than or equal to 90 mmHg, less than or equal to 85 mmHg, or less than or equal to 80 mmHg. </p> <p>In <a href="./references#CD008277-bbs2-0002" title="EstacioRO , JeffersBW , HiattWR , BiggerstaffSl , GiffordN , SchrierRW . The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non‐insulin‐dependent diabetes and hypertension. New England Journal of Medicine1998;338(10):645‐52. ">ABCD‐H 1998</a> and <a href="./references#CD008277-bbs2-0003" title="SchrierRW , EstacioRO , EslerA , MehlerP . Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney International2002;61(3):1086‐97. ">ABCD‐N 2002</a> the initial antihypertensive agent was either nisoldipine or enalapril, randomly assigned in a factorial way. Valsartan was the initial antihypertensive medication in <a href="./references#CD008277-bbs2-0001" title="EstacioRO , CollJR , TranZV , SchrierRW . Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes. American Journal of Hypertension2006;19(12):1241‐8. ">ABCD‐2V 2006</a>, following a established drug procedure afterwards. In <a href="./references#CD008277-bbs2-0005" title="HanssonL , ZanchettiA , CarruthersSG , DahlöfB , ElmfeldtB , JuliusS , et al. Effects of intensive blood‐pressure lowering and low‐dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. HOT Stdy Group. Lancet1998;351(9118):1755‐62. ">HOT 1998</a> felodipine was given as baseline therapy with the addition of other agents according to a five‐step regimen. No specific drug procedure was decribed in <a href="./references#CD008277-bbs2-0004" title="The ACCORD Study Group. Effects of intensive blood‐pressure control in type 2 diabetes mellitus. New England Journal of Medicine2010;362(17):1575‐85. ">ACCORD BP 2010</a>. </p> <p>In <a href="./references#CD008277-bbs2-0003" title="SchrierRW , EstacioRO , EslerA , MehlerP . Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney International2002;61(3):1086‐97. ">ABCD‐N 2002</a> and <a href="./references#CD008277-bbs2-0001" title="EstacioRO , CollJR , TranZV , SchrierRW . Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes. American Journal of Hypertension2006;19(12):1241‐8. ">ABCD‐2V 2006</a> participants assigned to the ‘standard’ therapy groups were given placebo initially. </p> <p>d. Outcomes:</p> <p>Several types of major cardiovascular events were the primary outcomes in <a href="./references#CD008277-bbs2-0004" title="The ACCORD Study Group. Effects of intensive blood‐pressure control in type 2 diabetes mellitus. New England Journal of Medicine2010;362(17):1575‐85. ">ACCORD BP 2010</a> and <a href="./references#CD008277-bbs2-0005" title="HanssonL , ZanchettiA , CarruthersSG , DahlöfB , ElmfeldtB , JuliusS , et al. Effects of intensive blood‐pressure lowering and low‐dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. HOT Stdy Group. Lancet1998;351(9118):1755‐62. ">HOT 1998</a>. Surrogate markers of renal function were the primary outcome in the ABCD trials (<a href="./references#CD008277-bbs2-0001" title="EstacioRO , CollJR , TranZV , SchrierRW . Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes. American Journal of Hypertension2006;19(12):1241‐8. ">ABCD‐2V 2006</a>, <a href="./references#CD008277-bbs2-0002" title="EstacioRO , JeffersBW , HiattWR , BiggerstaffSl , GiffordN , SchrierRW . The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non‐insulin‐dependent diabetes and hypertension. New England Journal of Medicine1998;338(10):645‐52. ">ABCD‐H 1998</a>, <a href="./references#CD008277-bbs2-0003" title="SchrierRW , EstacioRO , EslerA , MehlerP . Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney International2002;61(3):1086‐97. ">ABCD‐N 2002</a>) and some types of cardiovascular events were reported as secondary outcomes. </p> <p>e. Additional notes:</p> <p>The <a href="./references#CD008277-bbs2-0004" title="The ACCORD Study Group. Effects of intensive blood‐pressure control in type 2 diabetes mellitus. New England Journal of Medicine2010;362(17):1575‐85. ">ACCORD BP 2010</a> trial was sponsored by the National Heart, Lung, and Blood Institute (NHLBI) from the United States. The remaining trials were supported by pharmaceutical companies. </p> <p><a href="./references#CD008277-bbs2-0004" title="The ACCORD Study Group. Effects of intensive blood‐pressure control in type 2 diabetes mellitus. New England Journal of Medicine2010;362(17):1575‐85. ">ACCORD BP 2010</a> was conducted between January 2001 and October 2005. HOT was conducted between October 1992 and August 1997. The dates for the other trials were not specified. </p> </section> <section id="CD008277-sec-0046"> <h4 class="title">Excluded studies</h4> <p><b>United Kingdom Prospective Diabetes Study (</b><a href="./references#CD008277-bbs2-0010" title="Anon . Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 [Erratum]. BMJ1999;318(7175):29. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ1998;317(7160):703‐13. ">UKPDS 38 1998</a>) </p> <p>This study was excluded because the target for systolic blood pressure in the 'tight control' group was higher than stated in our protocol. In addition, and more importantly, the targets for both systolic and diastolic blood pressure in the 'less tight control' group were much higher than specified in the protocol for this systematic review.  </p> <p> <b>Hypertension in Diabetes Study IV (</b><a href="./references#CD008277-bbs2-0006" title="Anon . Hypertension in Diabetes Study IV. Therapeutic requirements to maintain tight blood presure control [Erratum]. Diabetologia1997;40(3):366. Hypertension in Diabetes Study Group. Hypertension in Diabetes Study IV. Therapeutic requirements to maintain tight blood presure control. Diabetologia1996;39(12):1554‐61. ">HDS 1996</a><b>)</b> </p> <p>This trial was excluded from the review for the same reasons as the UKPDS 38 trial. Furthermore, it is likely that participants in this trial represent a subgroup of participants included in UKPDS 38, because the study design is similar and the authors are the same.  </p> <p><b>SANDS (</b><a href="./references#CD008277-bbs2-0008" title="HowardBV , RomanMJ , DevereuxRB , FlegJL , GallowayJM , HendersonJA , et al. Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes. JAMA2008;299(14):1678‐89. ">SANDS 2008</a><b>)</b> </p> <p>This trial was not included because the dual intervention would not allow us to address the events specifically associated with a lower blood pressure target. Besides, both systolic blood pressure targets in this trial were within the values considered as 'lower targets' in our systematic review. </p> <p><b>Lewis et al</b> (<a href="./references#CD008277-bbs2-0007" title="LewisJB , BerlT , BainRP , RohdeRD , LewisEJ . Effect on intensive blood pressure control on the course of type 1 diabetic nephropathy. American Journal of Kidney Diseases1999;34(5):809‐17. ">Lewis 1999</a>) </p> <p>It was excluded because it did not provide data on any of the outcomes defined for this systematic review.  </p> <p><b>Steno‐2 study (</b><a href="./references#CD008277-bbs2-0009" title="GaedeP , VedelP , LarsenN , JensenGV , ParvingHH , PedersenO . Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. New England Journal of Medicine2003;348(5):383‐93. ">Steno‐2 2003</a><b>)</b> </p> <p>This trial was not included because the multifactorial intervention prevented any inference as to whether any difference in clinical outcomes could be attributed to a lower blood pressure target or to any of the other combined interventions. </p> </section> </section> <section id="CD008277-sec-0047"> <h3 class="title">Risk of bias in included studies</h3> <p>The summary of the risk of bias assessment of each trial is shown in <a href="#CD008277-fig-0002">Figure 2</a>. </p> <div class="figure" id="CD008277-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD008277-fig-0002" src="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_n/nCD008277-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD008277-sec-0048"> <h4 class="title">Allocation</h4> <p>In <a href="./references#CD008277-bbs2-0005" title="HanssonL , ZanchettiA , CarruthersSG , DahlöfB , ElmfeldtB , JuliusS , et al. Effects of intensive blood‐pressure lowering and low‐dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. HOT Stdy Group. Lancet1998;351(9118):1755‐62. ">HOT 1998</a> and <a href="./references#CD008277-bbs2-0004" title="The ACCORD Study Group. Effects of intensive blood‐pressure control in type 2 diabetes mellitus. New England Journal of Medicine2010;362(17):1575‐85. ">ACCORD BP 2010</a> randomization was performed centrally and computer‐generated. The method of randomization was not described in the other trials. </p> </section> <section id="CD008277-sec-0049"> <h4 class="title">Blinding</h4> <p>None of the trials was blinded to blood pressure goal because of the need to titrate treatment to achieve the specific target. Clinical events were evaluated in every trial by an independent committee masked to the group allocation. </p> </section> <section id="CD008277-sec-0050"> <h4 class="title">Incomplete outcome data</h4> <p>In the entire <a href="./references#CD008277-bbs2-0005" title="HanssonL , ZanchettiA , CarruthersSG , DahlöfB , ElmfeldtB , JuliusS , et al. Effects of intensive blood‐pressure lowering and low‐dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. HOT Stdy Group. Lancet1998;351(9118):1755‐62. ">HOT 1998</a> trial 2.6% of the participants were lost to follow‐up, and they were equally distributed between the target arms; such information is not available for the subgroup of diabetic participants. In <a href="./references#CD008277-bbs2-0004" title="The ACCORD Study Group. Effects of intensive blood‐pressure control in type 2 diabetes mellitus. New England Journal of Medicine2010;362(17):1575‐85. ">ACCORD BP 2010</a> 4.9% were lost to follow‐up, and their distribution is not known. No specific information about drop‐outs was provided in the remaining trial reports. </p> </section> <section id="CD008277-sec-0051"> <h4 class="title">Selective reporting</h4> <p>Some of the outcomes were not evaluated or reported in the trials. The clearest example of potential selective reporting bias is total serious adverse events, which were reported in only one trial. </p> </section> <section id="CD008277-sec-0052"> <h4 class="title">Other potential sources of bias</h4> <p>As explained in detail below, baseline characteristics in the ABCD trials differed between the 'lower' and the 'standard' target groups. </p> </section> </section> <section id="CD008277-sec-0053"> <h3 class="title" id="CD008277-sec-0053">Effects of interventions</h3> <p>See: <a href="./full#CD008277-tbl-0001"><b>Summary of findings for the main comparison</b> </a> </p> <p><b>1. Systolic blood pressure target</b> </p> <p>Only one randomized trial (<a href="./references#CD008277-bbs2-0004" title="The ACCORD Study Group. Effects of intensive blood‐pressure control in type 2 diabetes mellitus. New England Journal of Medicine2010;362(17):1575‐85. ">ACCORD BP 2010</a>) was identified comparing targets for systolic blood pressure within the definitions established for this review. The data were obtained from the main report of the trial and the published appendices.  </p> <p>1.1  Total mortality </p> <p>There was no difference in total mortality between the two blood pressure target groups: risk ratio (RR) 1.05, 95% confidence interval (CI) 0.84 to 1.30, P = 0.69 (<a href="./references#CD008277-fig-0003" title="">Analysis 1.1</a>). </p> <p>1.2  Cardiovascular (CV) mortality </p> <p>There was no difference in cardiovascular mortality between the two blood pressure target groups: RR 1.04, 95% CI 0.73 to 1.48, P = 0.84 (<a href="./references#CD008277-fig-0004" title="">Analysis 1.2</a>). </p> <p>1.3  Non‐CV mortality </p> <p>There was no difference in non‐cardiovascular mortality between the two blood pressure target groups: RR 1.05, 95% CI 0.79 to 1.40, P = 0.74 (<a href="./references#CD008277-fig-0005" title="">Analysis 1.3</a>). </p> <p>1.4  Total serious adverse events </p> <p>The total number of serious adverse events was not reported in the <a href="./references#CD008277-bbs2-0004" title="The ACCORD Study Group. Effects of intensive blood‐pressure control in type 2 diabetes mellitus. New England Journal of Medicine2010;362(17):1575‐85. ">ACCORD BP 2010</a> trial. We calculated the sum of total mortality, non‐fatal myocardial infarction, non‐fatal stroke, non‐fatal heart failure, end‐stage renal disease or need for dialysis, and other serious adverse events attributed to blood pressure medications. There was no difference in the calculated total serious adverse events between the two blood pressure target groups: RR 1.01, 95% CI 0.91 to 1.13, P = 0.81 (<a href="./references#CD008277-fig-0006" title="">Analysis 1.4</a>). </p> <p>1.5  Myocardial infarction </p> <p>There were 133 myocardial infarctions (126 non‐fatal) in the intensive therapy group and 151 (146 non‐fatal) in the standard therapy group, with no significant difference between the groups: RR 0.88, 95% CI 0.71 to 1.11, P = 0.28 (<a href="./references#CD008277-fig-0007" title="">Analysis 1.5</a>). </p> <p>1.6  Stroke </p> <p>There were 36 strokes (34 non‐fatal) in the intensive therapy group and 62 (55 non‐fatal) in the standard therapy group. The difference between the groups was statistically significant: RR 0.58, 95% CI 0.39 to 0.88, P = 0.009, absolute risk reduction 1.1% (<a href="./references#CD008277-fig-0008" title="">Analysis 1.6</a>).   </p> <p>1.7  Congestive heart failure </p> <p>There was no difference in fatal or non‐fatal heart failure between the two blood pressure target groups: RR 0.93, 95% CI 0.69 to 1.24, P = 0.60 (<a href="./references#CD008277-fig-0009" title="">Analysis 1.7</a>). </p> <p>1.8  End‐stage renal failure </p> <p>There was no difference in end‐stage renal failure or need for dialysis between the two blood pressure target groups: RR 1.02, 95% CI 0.71 to 1.46, P = 0.84 (<a href="./references#CD008277-fig-0010" title="">Analysis 1.8</a>). </p> <p>1.9  All other serious adverse events </p> <p>The <a href="./references#CD008277-bbs2-0004" title="The ACCORD Study Group. Effects of intensive blood‐pressure control in type 2 diabetes mellitus. New England Journal of Medicine2010;362(17):1575‐85. ">ACCORD BP 2010</a> investigators reported separately other serious adverse events attributed to blood pressure medications, including hypotension, syncope, bradycardia or arrhythmia, hyperkalemia, angioedema, and renal failure. These serious adverse events were significantly more prevalent in the 'intensive therapy' group: RR 2.58, 95% CI 1.70 to 3.91, P &lt; 0.00001, absolute risk increase 2.0% (<a href="./references#CD008277-fig-0011" title="">Analysis 1.9</a>). </p> <p>1.10  Systolic blood pressure achieved </p> <p>After the first year of therapy, the average systolic blood pressure achieved was significantly lower in the 'intensive therapy' group, mean difference 14.2 mmHg, P &lt; 0.00001 (119.3 mmHg vs 133.5 mmHg in the 'intensive' vs the 'standard' groups respectively; <a href="./references#CD008277-fig-0012" title="">Analysis 1.10</a>). </p> <p>1.11  Diastolic blood pressure achieved </p> <p>After the first year of therapy, the average diastolic blood pressure achieved was significantly lower in the 'intensive therapy' group, mean difference 6.1 mmHg, P &lt; 0.00001 (64.4 mmHg vs 70.5 mmHg in the 'intensive' vs the 'standard' groups respectively; <a href="./references#CD008277-fig-0013" title="">Analysis 1.11</a>). </p> <p>1.12 Withdrawals due to adverse events </p> <p>There is no information available.</p> <p>1.13  Number of antihypertensive drugs used </p> <p>The mean number of antihypertensive drugs used after the first year was significantly greater in the 'intensive therapy' group (3.4 vs 2.1), P &lt; 0.00001; <a href="./references#CD008277-fig-0014" title="">Analysis 1.13</a>. </p> <p> <b>2. Diastolic blood pressure (DBP) target</b> </p> <p>Three trials compared clinical outcomes associated with different diastolic blood pressure targets specifically in people with diabetes (<a href="./references#CD008277-bbs2-0002" title="EstacioRO , JeffersBW , HiattWR , BiggerstaffSl , GiffordN , SchrierRW . The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non‐insulin‐dependent diabetes and hypertension. New England Journal of Medicine1998;338(10):645‐52. ">ABCD‐H 1998</a>; <a href="./references#CD008277-bbs2-0003" title="SchrierRW , EstacioRO , EslerA , MehlerP . Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney International2002;61(3):1086‐97. ">ABCD‐N 2002</a>; <a href="./references#CD008277-bbs2-0001" title="EstacioRO , CollJR , TranZV , SchrierRW . Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes. American Journal of Hypertension2006;19(12):1241‐8. ">ABCD‐2V 2006</a>). Although it enrolled non‐diabetic participants, the <a href="./references#CD008277-bbs2-0005" title="HanssonL , ZanchettiA , CarruthersSG , DahlöfB , ElmfeldtB , JuliusS , et al. Effects of intensive blood‐pressure lowering and low‐dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. HOT Stdy Group. Lancet1998;351(9118):1755‐62. ">HOT 1998</a> trial could be included in this analysis because it reported outcomes in the subgroup of participants with diabetes separately. Some outcomes, not provided in the published reports of the trials, were obtained from the Blood Pressure Lowering Treatment Trialists` Collaboration (<a href="./references#CD008277-bbs2-0023" title="TurnbullF , Blood Pressure Lowering Treatment Trialists´ Collaboration. Effects of different blood‐pressure‐lowering regimens on major cardiovascular events: results of prospectively‐designed overviews of randomised trials. Lancet2003;362(9395):1527‐35. ">BPLTTC 2003</a>). </p> <p>Several issues regarding the design and the characteristics of these trials must be mentioned before analyzing the results: </p> <p>a.  Regarding baseline characteristics, if the three ABCD trials are combined, a significantly greater proportion of participants randomized to 'standard target' had established cardiovascular or cerebrovascular disease compared with the 'lower target' group (41.0% vs 33.5%, P = 0.007). This difference in baseline characteristics is important and would be expected to have an impact on the clinical outcomes against the 'standard target' group, because having a greater proportion of participants with established vascular disease increases the risk of having future events. The magnitude of this potential bias is increased by the fact that the ABCD trials account for 42% of the total number of participants included in the analysis for diastolic BP targets. </p> <p>In the <a href="./references#CD008277-bbs2-0005" title="HanssonL , ZanchettiA , CarruthersSG , DahlöfB , ElmfeldtB , JuliusS , et al. Effects of intensive blood‐pressure lowering and low‐dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. HOT Stdy Group. Lancet1998;351(9118):1755‐62. ">HOT 1998</a> trial, randomization was blocked for several factors, including diabetes mellitus, and therefore it is possible that baseline characteristics of participants with diabetes were similar between the target blood pressure groups, but the details are not available and therefore the potential for bias also exists for this trial. </p> <p>b.  In terms of inclusion criteria, the <a href="./references#CD008277-bbs2-0003" title="SchrierRW , EstacioRO , EslerA , MehlerP . Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney International2002;61(3):1086‐97. ">ABCD‐N 2002</a> and <a href="./references#CD008277-bbs2-0001" title="EstacioRO , CollJR , TranZV , SchrierRW . Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes. American Journal of Hypertension2006;19(12):1241‐8. ">ABCD‐2V 2006</a> trials included only normotensive diabetic participants, defined as having a diastolic blood pressure between 80 and 89 mmHg. Twenty‐six participants (5.4%) with isolated systolic hypertension (systolic blood pressure greater than 160 mmHg and diastolic blood pressure between 80 and 89 mmHg) were enrolled in <a href="./references#CD008277-bbs2-0003" title="SchrierRW , EstacioRO , EslerA , MehlerP . Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney International2002;61(3):1086‐97. ">ABCD‐N 2002</a> during the first year of recruitment, but none thereafter. On the other hand, <a href="./references#CD008277-bbs2-0002" title="EstacioRO , JeffersBW , HiattWR , BiggerstaffSl , GiffordN , SchrierRW . The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non‐insulin‐dependent diabetes and hypertension. New England Journal of Medicine1998;338(10):645‐52. ">ABCD‐H 1998</a> and <a href="./references#CD008277-bbs2-0005" title="HanssonL , ZanchettiA , CarruthersSG , DahlöfB , ElmfeldtB , JuliusS , et al. Effects of intensive blood‐pressure lowering and low‐dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. HOT Stdy Group. Lancet1998;351(9118):1755‐62. ">HOT 1998</a> only included participants with elevated blood pressure, but the criteria for inclusion were different. In <a href="./references#CD008277-bbs2-0002" title="EstacioRO , JeffersBW , HiattWR , BiggerstaffSl , GiffordN , SchrierRW . The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non‐insulin‐dependent diabetes and hypertension. New England Journal of Medicine1998;338(10):645‐52. ">ABCD‐H 1998</a> participants had a baseline diastolic blood pressure equal to or higher than 90 mmHg, whereas an inclusion criterion in <a href="./references#CD008277-bbs2-0005" title="HanssonL , ZanchettiA , CarruthersSG , DahlöfB , ElmfeldtB , JuliusS , et al. Effects of intensive blood‐pressure lowering and low‐dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. HOT Stdy Group. Lancet1998;351(9118):1755‐62. ">HOT 1998</a> was a baseline diastolic blood pressure between 100 and 115 mmHg. </p> <p>c.  When the <a href="./references#CD008277-bbs2-0005" title="HanssonL , ZanchettiA , CarruthersSG , DahlöfB , ElmfeldtB , JuliusS , et al. Effects of intensive blood‐pressure lowering and low‐dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. HOT Stdy Group. Lancet1998;351(9118):1755‐62. ">HOT 1998</a>, <a href="./references#CD008277-bbs2-0002" title="EstacioRO , JeffersBW , HiattWR , BiggerstaffSl , GiffordN , SchrierRW . The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non‐insulin‐dependent diabetes and hypertension. New England Journal of Medicine1998;338(10):645‐52. ">ABCD‐H 1998</a> and <a href="./references#CD008277-bbs2-0003" title="SchrierRW , EstacioRO , EslerA , MehlerP . Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney International2002;61(3):1086‐97. ">ABCD‐N 2002</a> trials were conducted, the diagnostic criteria for diabetes mellitus were different from those currently used. At that time, diabetes mellitus was defined as two fasting plasma glucose levels, measured on different days, higher than 7.7 mmol/L (140 mg/dL), instead of 7.0 mmol/L (126 mg/dL), as currently defined. </p> <p> 2.1 Total mortality </p> <p>The data on mortality from <a href="./references#CD008277-bbs2-0002" title="EstacioRO , JeffersBW , HiattWR , BiggerstaffSl , GiffordN , SchrierRW . The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non‐insulin‐dependent diabetes and hypertension. New England Journal of Medicine1998;338(10):645‐52. ">ABCD‐H 1998</a> deserve an explanation. The first publication of the trial (<a href="./references#CD008277-bbs2-0002" title="EstacioRO , JeffersBW , HiattWR , BiggerstaffSl , GiffordN , SchrierRW . The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non‐insulin‐dependent diabetes and hypertension. New England Journal of Medicine1998;338(10):645‐52. ">ABCD‐H 1998</a>) mentioned 30 death in total, but it did not provide details on the distribution according to blood pressure targets. Later publications stated that “patients randomized to intensive therapy had a lower incidence of all‐cause mortality when compared to moderate therapy, 5.5% vs 10.7%, p= 0.037” (<a href="./references#CD008277-bbs2-0012" title="EstacioRO , GiffordN , JeffersBW , SchrierRW . Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Diabetes Care2000;23(Suppl 2):B54‐64. ">ABCD‐H 2000</a>; <a href="./references#CD008277-bbs2-0011" title="SchrierRW , EstacioRO , MehlerPS , HiattWR . Appropriate blood pressure control in hypertensive and normotensive type 2 diabetes mellitus: a summary of the ABCD trial. Nature Clinical Practice: Nephrology2007;3(8):428‐38. ">ABCD 2007</a>), without providing absolute numbers. Given that 237 participants were assigned to the intensive treatment group, and 233 participants to the moderate treatment group, the absolute number of deaths calculated from the reported percentages would be 13 and 25 respectively, for a total of 38 deaths, which differs from the total mortality mentioned in the first report. Finally, the Blood Pressure Lowering Treatment Trialists`Collaboration reported 32 deaths in the same trial, 10 in the intensive treatment group and 22 in the moderate treatment group (<a href="./references#CD008277-bbs2-0023" title="TurnbullF , Blood Pressure Lowering Treatment Trialists´ Collaboration. Effects of different blood‐pressure‐lowering regimens on major cardiovascular events: results of prospectively‐designed overviews of randomised trials. Lancet2003;362(9395):1527‐35. ">BPLTTC 2003</a>). Due to the lack of concordance, the information from the BPLLTTC was used for this analysis, because it was the only one providing absolute numbers and because they were closer to the figures mentioned in the original report. </p> <p>There was a statistically non‐significant trend toward reduced risk of total mortality in the 'lower target' group: RR 0.73, 95% CI 0.53 to 1.01, P = 0.05 (<a href="./references#CD008277-fig-0015" title="">Analysis 2.1</a>).  </p> <p>2.2 Cardiovascular mortality </p> <p>There was no difference in cardiovascular mortality between the '''lower target' and the 'standard target' groups: RR 0.79, 95% CI 0.52 to 1.19, P = 0.26 (<a href="./references#CD008277-fig-0016" title="">Analysis 2.2</a>). </p> <p>2.3 Non‐CV mortality </p> <p>There was no difference in non‐cardiovascular mortality in the 'lower target' compared with the 'standard target' group: RR 0.62, 95% CI 0.36 to 1.06, P = 0.08 (<a href="./references#CD008277-fig-0017" title="">Analysis 2.3</a>). </p> <p>2.4 Total serious adverse events </p> <p>Total serious adverse events were not reported in any of the trials.</p> <p>2.5 Myocardial infarction </p> <p>There was no difference in the incidence of myocardial infarction between the 'lower target' and the 'standard target' groups: RR 0.95, 95% CI 0.64 to 1.40, P = 0.79 (<a href="./references#CD008277-fig-0018" title="">Analysis 2.5</a>). </p> <p>2.6 Stroke </p> <p>There was no difference in the incidence of stroke in the 'lower target' compared with the 'standard target' group, RR 0.67, 95% CI 0.42 to 1.05), P = 0.08 (<a href="./references#CD008277-fig-0019" title="">Analysis 2.6</a>). </p> <p>2.7 Congestive heart failure </p> <p>Data on this outcome from the subgroup of participants with diabetes included in <a href="./references#CD008277-bbs2-0005" title="HanssonL , ZanchettiA , CarruthersSG , DahlöfB , ElmfeldtB , JuliusS , et al. Effects of intensive blood‐pressure lowering and low‐dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. HOT Stdy Group. Lancet1998;351(9118):1755‐62. ">HOT 1998</a> and the <a href="./references#CD008277-bbs2-0001" title="EstacioRO , CollJR , TranZV , SchrierRW . Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes. American Journal of Hypertension2006;19(12):1241‐8. ">ABCD‐2V 2006</a> trial are not available. Data from <a href="./references#CD008277-bbs2-0002" title="EstacioRO , JeffersBW , HiattWR , BiggerstaffSl , GiffordN , SchrierRW . The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non‐insulin‐dependent diabetes and hypertension. New England Journal of Medicine1998;338(10):645‐52. ">ABCD‐H 1998</a> were provided by BPLTTC. There was no difference in the incidence between the two treatment target groups: RR 1.06, 95% CI 0.58 to 1.92, P = 0.86 (<a href="./references#CD008277-fig-0020" title="">Analysis 2.7</a>). </p> <p>2.8 End‐stage renal failure </p> <p>End‐stage renal failure was not reported in any of the trials.</p> <p>2.9 All other serious adverse events </p> <p>All other serious adverse events were not reported in any of the trials.</p> <p>2.10 Systolic blood pressure achieved </p> <p>No information is available from the subgroup of participants with diabetes in <a href="./references#CD008277-bbs2-0005" title="HanssonL , ZanchettiA , CarruthersSG , DahlöfB , ElmfeldtB , JuliusS , et al. Effects of intensive blood‐pressure lowering and low‐dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. HOT Stdy Group. Lancet1998;351(9118):1755‐62. ">HOT 1998</a>. The average systolic blood pressure achieved in the ABCD trials was significantly lower in the 'lower target' group, mean difference 7.31 mmHg, P &lt; 0.00001 (mean SBP = 128 mmHg vs 135 mmHg in the 'lower target' vs the 'standard target' groups respectively; <a href="./references#CD008277-fig-0021" title="">Analysis 2.10</a>). </p> <p>2.11   Diastolic blood pressure achieved </p> <p>No information is available from the subgroup of participants with diabetes in <a href="./references#CD008277-bbs2-0005" title="HanssonL , ZanchettiA , CarruthersSG , DahlöfB , ElmfeldtB , JuliusS , et al. Effects of intensive blood‐pressure lowering and low‐dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. HOT Stdy Group. Lancet1998;351(9118):1755‐62. ">HOT 1998</a>. The average diastolic blood pressure achieved in the ABCD trials was significantly lower in the 'lower target' group, mean difference 6.85 mmHg, P &lt; 0.00001 (mean DBP= 76 mmHg vs 83 mmHg in the 'lower target' vs the 'standard target' groups respectively; <a href="./references#CD008277-fig-0022" title="">Analysis 2.11</a>). </p> <p>2.12   Withdrawals due to adverse effects </p> <p>Withdrawals due to adverse events were not reported in any of the trials.</p> <p>2.13   Number of antihypertensive drugs used </p> <p>The number of antihypertensive drugs used was not reported in any of the trials.</p> <p><b>Sensitivity analysis for diastolic blood pressure &lt; 80 mm Hg vs &lt; 90 mm Hg</b> </p> <p>Because clinical guidelines recommend a diastolic blood pressure target lower than 80 mmHg, we decided to perform a sensitivity analysis in trials comparing a target of lower than 80 mmHg versus the standard target of lower than 90 mmHg. This sensitivity analysis only excluded the treatment arm lower than 85 mmHg from the <a href="./references#CD008277-bbs2-0005" title="HanssonL , ZanchettiA , CarruthersSG , DahlöfB , ElmfeldtB , JuliusS , et al. Effects of intensive blood‐pressure lowering and low‐dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. HOT Stdy Group. Lancet1998;351(9118):1755‐62. ">HOT 1998</a> trial. It therefore has the same limitations described for the entire analysis on DBP, except that in this case the unbalance in baseline characteristics against the standard target from the ABCD trials has a more pronounced effect because they represent more than 50% of the total population.  </p> <p>The results from this sensitivity analysis are shown in the following table. They are very similar to the entire analysis for DBP mentioned above. In this case the reduction in total mortality associated with the lower target achieved statistical significance. The contributions from both cardiovascular and non‐CV mortality were numerically similar.  </p> <p> <div class="table" id="CD008277-tblf-0001"> <table> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Effect estimate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Total mortality</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2079</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.64, 95% CI 0.45 to 0.92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.02</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiovascular mortality</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1950</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.64, 95% CI 0.39 to 1.03</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.07</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Non‐cardiovascular mortality</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1950</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.62, 95% CI 0.35 to 1.08</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.09</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Total serious adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Myocardial infarction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2079</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.98, 95% CI 0.65 to 1.48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.93</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Stroke</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2079</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.64, 95% CI 0.39to 1.06</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.08</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Congestive heart failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>950</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.06, 95% CI 0.58 to 1.92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.86</p> </td> </tr> </tbody> </table> </div> </p> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD008277-sec-0054" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD008277-sec-0054"></div> <p>This systematic review and meta‐analysis summarizes the available evidence from randomized trials that have evaluated clinical outcomes associated with 'lower' versus 'standard' blood pressure (BP) targets, as previously defined, in participants with diabetes mellitus. Even though a review of people with diabetes and hypertension can be considered as a subgroup analysis of the hypertensive population, the approach is justified because most of the trials were conducted specifically in people with diabetes, for whom different BP targets have been proposed. </p> <p>We found five randomized trials, with a total of 7314 participants, and a mean follow‐up period of 4.5 years. </p> <p>Even though pharmacological treatment usually decreases both systolic and diastolic blood pressure, we decided to analyze each target separately, because each one of them really constitutes an individual target in clinical practice. For example, current medical practice is to start pharmacological antihypertensive therapy when either systolic blood pressure (SBP) or diastolic blood pressure (DBP) remains elevated despite non‐pharmacologic strategies. If both SBP and DBP are elevated, the recommendation is to adjust drug regimens until both targets are achieved. Besides, systolic and diastolic pressures are determined by different pathophysiological mechanisms and can be associated with different clinical implications (systolic BP is a constant risk factor at all ages, whereas diastolic BP is mainly a risk factor in younger people). Finally, combining trials evaluating SBP and DBP targets can be misleading because both pressures may not decrease to the same extent, and therefore the treatment strategy may differ. For example, a pharmacological strategy to achieve a 'standard' target in SBP could produce a very intense decrease in DBP within the range defined for the 'intensive' target. In fact, that situation occurred in the <a href="./references#CD008277-bbs2-0004" title="The ACCORD Study Group. Effects of intensive blood‐pressure control in type 2 diabetes mellitus. New England Journal of Medicine2010;362(17):1575‐85. ">ACCORD BP 2010</a> trial, where participants assigned to the 'standard' systolic target achieved a mean DBP well below our definition for the 'lower' target. </p> <section id="CD008277-sec-0055"> <h3 class="title" id="CD008277-sec-0055">Summary of main results</h3> <p><b>Systolic blood pressure (SBP) target:</b> </p> <p>No randomized trial has ever evaluated directly clinical outcomes associated with a SBP less than 130 mmHg as recommended in most clinical guidelines for people with diabetes. <a href="./references#CD008277-bbs2-0004" title="The ACCORD Study Group. Effects of intensive blood‐pressure control in type 2 diabetes mellitus. New England Journal of Medicine2010;362(17):1575‐85. ">ACCORD BP 2010</a> is the only trial that has evaluated outcomes associated with systolic blood pressure targets within the range established as 'lower' or 'standard' and it clearly stated that trying to achieve a SBP lower than 120 mmHg instead of lower than 140 mmHg was associated with an isolated benefit in the risk of stroke. Even though it was statistically significant, its magnitude was small, with an absolute risk reduction of 1.1%, which means that 91 people must be treated intensively during 4.7 years to prevent one additional stroke. Moreover, the benefit in stroke was counterbalanced by a significant absolute risk increase of 2% in other serious adverse events attributed to blood pressure medications, which means that one excessive serious adverse event occurred for every 50 people treated intensively.  </p> <p>Three main issues have arisen from the <a href="./references#CD008277-bbs2-0004" title="The ACCORD Study Group. Effects of intensive blood‐pressure control in type 2 diabetes mellitus. New England Journal of Medicine2010;362(17):1575‐85. ">ACCORD BP 2010</a> results: </p> <p>1.  Maybe the systolic target of lower than 120 mmHg was too low, and could have produced a J‐curve phenomenon. Whether a target lower than 130 mmHg instead of lower than 120 mmHg would avoid that potential inconvenience is unknown.<br/>  2.  Based on the previous argument, it has been suggested that tight BP control could be beneficial if implemented early (<a href="./references#CD008277-bbs2-0055" title="ZanchettiA . Bottom blood pressure or bottom cardiovascular risk? How far can cardiovascular risk be reduced?. Journal of Hypertension2009;27(8):1509‐20. ">Zanchetti 2009</a>; <a href="./references#CD008277-bbs2-0045" title="ParatiG , BiloG , OchoaJE . Benefits of tight blood pressure control in diabetic patients with hypertension. Importance of early and sustained implementation of effective treatment strategies. Diabetes Care2011;34(Suppl 2):S297‐303. ">Parati 2011</a>). For example, young people with diabetes, who are in the early stages of the vascular atherosclerotic process, could benefit from a lower target without the potential risk of a J‐curve phenomenon. However, this interesting argument mentioned in one of the most recent clinical guidelines (<a href="./references#CD008277-bbs2-0014" title="American Diabetes Association. Standards of medical care in diabetes 2013. Diabetes Care2013;36(Suppl 1):S11‐66. ">ADA 2013</a>) is not supported by evidence, and it must be properly evaluated and proved before being implemented in clinical practice.<br/> 3.  It has also been proposed that the risk/benefit ratio associated with the lower target could be acceptable for people at high risk of stroke, such as people with diabetes with a history of cerebrovascular disease (<a href="./references#CD008277-bbs2-0040" title="ManciaG , GrassiG , ZanchettiA . Antihypertensive treatment and blood pressure in diabetic and nondiabetic patients. The lower, the better?. Diabetes Care2011;34(Suppl 2):304‐7. ">Mancia 2011</a>). Once again, this idea must be properly evaluated.     </p> <p><b>Diastolic blood pressure (DBP) target:</b> </p> <p>The four remaining trials evaluated DBP targets according to our definitions. There was a trend of borderline statistical significance toward a decrease in total mortality (RR 0.73, 95% CI 0.53, 1.01, P = 0.05) associated with the 'lower target'. However, a more detailed analysis leads one not to place much weight on this finding: </p> <p>1.  The trend toward a decrease in total mortality was mainly driven by the non‐cardiovascular causes of death. It is hard to explain how a more intensive antihypertensive therapy can decrease the mortality due to non‐cardiovascular causes.<br/> 2.  There was no difference in other clinical outcomes.<br/> 3. As previously mentioned, there is a high risk of bias in these trials. The main potential sources of bias are the subgroup analysis in the <a href="./references#CD008277-bbs2-0005" title="HanssonL , ZanchettiA , CarruthersSG , DahlöfB , ElmfeldtB , JuliusS , et al. Effects of intensive blood‐pressure lowering and low‐dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. HOT Stdy Group. Lancet1998;351(9118):1755‐62. ">HOT 1998</a> trial, and a greater proportion of participants with established cardiovascular disease at baseline assigned to the 'standard' BP target in the ABCD trials, which might have biased the results against the 'standard' target group.<br/> 4.  The trials were performed when the diagnostic criteria for diabetes were less strict than the currently applied criteria. Besides, other preventive cardiovascular pharmacological resources frequently used in current medical practice were seldom used when the trials were performed.  Therefore, participants included in those trials may differ in several aspects from many people with diabetes in current medical practice.<br/> 5.  The lack of information on total serious adverse events and on withdrawals due to adverse effects precludes a global assessment of the benefits and harms ratio.<br/> 6.  Most of the outcomes had wide confidence intervals because the total number of trial participants was small. </p> </section> <section id="CD008277-sec-0056"> <h3 class="title" id="CD008277-sec-0056">Overall completeness and applicability of evidence</h3> <p>Hypertension and diabetes are highly prevalent conditions, frequently coexisting in the same patient. Treating hypertension is therefore an important part of the medical care of people with diabetes. The intensity of the antihypertensive treatment is greatly determined by the blood pressure target. Despite those important facts, the available evidence from randomized trials to define the optimal blood pressure targets is scanty.  </p> <p>For SBP, the <a href="./references#CD008277-bbs2-0004" title="The ACCORD Study Group. Effects of intensive blood‐pressure control in type 2 diabetes mellitus. New England Journal of Medicine2010;362(17):1575‐85. ">ACCORD BP 2010</a> trial provides very useful information. However, as mentioned before, there are many important unanswered questions.  </p> <p>The situation is more critical for DBP. The evidence is provided by an insufficient number of participants, under conditions that differ in several aspects from current medical practice, and is associated with a high risk of bias.     </p> </section> <section id="CD008277-sec-0057"> <h3 class="title" id="CD008277-sec-0057">Quality of the evidence</h3> <p>We downgraded the quality of evidence to low or very low for the outcomes of mortality and serious adverse events (<a href="./full#CD008277-tbl-0001">summary of findings Table for the main comparison</a>). This was primarily due to imprecision of effect estimates from the systolic target trial, and due to imprecision and very serious risk of bias in the diastolic target trials.  </p> </section> <section id="CD008277-sec-0058"> <h3 class="title" id="CD008277-sec-0058">Potential biases in the review process</h3> <p>The main potential bias is due to the fact that studies were not blinded. Lack of blinding is necessary because adjustments in the treatment must be performed when trying to achieve a specific blood pressure target. However, lack of blinding may lead to ascertainment bias when investigators are adjudicating outcomes. </p> <p>The trials at the highest risk for other types of biases were the <a href="./references#CD008277-bbs2-0005" title="HanssonL , ZanchettiA , CarruthersSG , DahlöfB , ElmfeldtB , JuliusS , et al. Effects of intensive blood‐pressure lowering and low‐dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. HOT Stdy Group. Lancet1998;351(9118):1755‐62. ">HOT 1998</a> trial (because it is a subgroup analysis) and the ABCD trials, because of  important differences in baseline characteristics suggesting that adequate sequence generation or allocation concealment or both were not achieved. </p> </section> <section id="CD008277-sec-0059"> <h3 class="title" id="CD008277-sec-0059">Agreements and disagreements with other studies or reviews</h3> <p>The main disagreement relates to clinical guidelines, which based their recommendations mainly on observational data or on post hoc analyses of achieved blood pressures in outcome trials. It must be remembered that observational studies are very susceptible to selection bias and to other confounding factors. The interpretation of outcome trials based on achieved blood pressure, rather than on the allocated treatment target, is also misleading, because it neglects the basic principles of randomization and intention‐to‐treat analysis. Looking at the cohort of participants with lower achieved blood pressure probably selects for those who had the lowest baseline blood pressure, for those in whom the blood pressure was most easily reduced with low doses of antihypertensive drugs, and for those who are more compliant with drug and non‐drug therapies. All of these factors are associated with a lower risk of having a cardiovascular event.   </p> <p>To the best of our knowledge, three meta‐analyses have evaluated similar questions. A meta‐analysis of randomized controlled trials in people with diabetes or impaired fasting glucose analyzed outcomes according to achieved, rather than targeted, blood pressures, in trials designed to test different hypotheses (<a href="./references#CD008277-bbs2-0020" title="BangaloreS , KumarS , LobachI , MesserliFH . Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose.  Observations from traditional and Bayesian random‐effects meta‐analyses of randomized trials. Circulation2011;123(24):2799‐810. ">Bangalore 2011</a>). It must be noted that 10 of the 13 trials included in that meta‐analysis were not designed to compare outcomes specifically associated with different BP targets, and therefore other factors could potentially influence the results. Despite those important methodological differences, and a somewhat different conclusion, the results were very similar to ours. In fact, the author of the editorial accompanying that meta‐analysis states that the data “do not support an across‐the‐board strategy of lowering SBP to ≤ 135 mmHg because their findings did not reveal significant benefit of intensive BP‐lowering strategy over the standard BP control strategy on macrovascular and microvascular events”  (<a href="./references#CD008277-bbs2-0026" title="DeedwaniaPC . Blood pressure control in diabetes mellitus.  Is lower always better, and how low it should go?. Circulation2011;123(24):2776‐8. ">Deedwania 2011</a>). With greater SBP reduction (lower than 130 mmHg), the only additional benefit found was an isolated decrease in the risk of stroke, but with an increased risk of serious adverse events. They conducted no analysis regarding DBP. </p> <p>Another meta‐analysis compared clinical outcomes associated with different BP intervention strategies in people with diabetes (<a href="./references#CD008277-bbs2-0047" title="ReboldiG , GentileG , AngeliF , AmbrosioG , ManciaG , VerdecchiaP , etal  . Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta‐analysis in 73913 patients. Journal of Hypertension2011;29(7):1253‐69. ">Reboldi 2011</a>). One of the comparisons performed was “more tight” versus “less tight” BP control, without defining specific values for those categories. As a result, they combined trials evaluating SBP and DBP targets, and also included the <a href="./references#CD008277-bbs2-0010" title="Anon . Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 [Erratum]. BMJ1999;318(7175):29. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ1998;317(7160):703‐13. ">UKPDS 38 1998</a> trial which was excluded from our analysis. As mentioned before, the reasons for excluding <a href="./references#CD008277-bbs2-0010" title="Anon . Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 [Erratum]. BMJ1999;318(7175):29. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ1998;317(7160):703‐13. ">UKPDS 38 1998</a> from our review were two‐fold:  firstly, the target for the 'low target' group in UKPDS 38 was 150/85 mmHg. This target is in the range for the 'standard target' for systolic blood pressure in our review; secondly, the blood pressure target in the less intensive treatment group was less than 200/105 mmHg, and after five years it was reduced to less than 180/105 mmHg. These high targets are very similar to the cutoffs for the no‐treatment group in trials comparing treatment with no treatment, and were abandoned in clinical practice many years ago. The inclusion of <a href="./references#CD008277-bbs2-0010" title="Anon . Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 [Erratum]. BMJ1999;318(7175):29. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ1998;317(7160):703‐13. ">UKPDS 38 1998</a> is therefore misleading and inappropriate when comparing 'lower' and 'standard' blood pressure targets in current medical practice. </p> <p>Finally, another meta‐analysis combined randomized trials comparing both systolic and diastolic blood pressure targets together (<a href="./references#CD008277-bbs2-0041" title="McBrienK , RabiDM , CampbellN , BarniehL , ClementF , HemmelgarnBR , et al. Intensive and standard blood pressure targets in patients with type 2 diabetes mellitus.  Systematic review and meta‐analysis. Archives of Internal Medicine2012;172(17):1296‐303. ">McBrien 2012</a>).  This meta‐analysis compared an intensive target defined as less than 130/80 mmHg with a standard target defined as less than 140 ‐ 160/85 ‐ 100 mmHg. There was statistical between‐studies heterogeneity. It showed that the intensive target was associated with a small reduction in stroke, without changing the risk for mortality or myocardial infarction. As mentioned above, we think that combining targets for SBP and DBP has a number of limitations. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD008277-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/urn:x-wiley:14651858:media:CD008277:CD008277-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_t/tCD008277-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Results of the search." data-id="CD008277-fig-0001" src="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_n/nCD008277-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Results of the search.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/full#CD008277-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_n/nCD008277-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008277-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/urn:x-wiley:14651858:media:CD008277:CD008277-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_t/tCD008277-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD008277-fig-0002" src="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_n/nCD008277-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/full#CD008277-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_n/nCD008277-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008277-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/urn:x-wiley:14651858:media:CD008277:CD008277-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_t/tCD008277-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Systolic blood pressure, Outcome 1 Total mortality." data-id="CD008277-fig-0003" src="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_n/nCD008277-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Systolic blood pressure, Outcome 1 Total mortality.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/references#CD008277-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_n/nCD008277-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008277-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/urn:x-wiley:14651858:media:CD008277:CD008277-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_t/tCD008277-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Systolic blood pressure, Outcome 2 Cardiovascular mortality." data-id="CD008277-fig-0004" src="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_n/nCD008277-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Systolic blood pressure, Outcome 2 Cardiovascular mortality.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/references#CD008277-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_n/nCD008277-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008277-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/urn:x-wiley:14651858:media:CD008277:CD008277-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_t/tCD008277-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Systolic blood pressure, Outcome 3 Non‐CV mortality." data-id="CD008277-fig-0005" src="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_n/nCD008277-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Systolic blood pressure, Outcome 3 Non‐CV mortality.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/references#CD008277-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_n/nCD008277-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008277-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/urn:x-wiley:14651858:media:CD008277:CD008277-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_t/tCD008277-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Systolic blood pressure, Outcome 4 Total serious adverse events." data-id="CD008277-fig-0006" src="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_n/nCD008277-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Systolic blood pressure, Outcome 4 Total serious adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/references#CD008277-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_n/nCD008277-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008277-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/urn:x-wiley:14651858:media:CD008277:CD008277-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_t/tCD008277-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Systolic blood pressure, Outcome 5 Myocardial infarction." data-id="CD008277-fig-0007" src="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_n/nCD008277-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Systolic blood pressure, Outcome 5 Myocardial infarction.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/references#CD008277-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_n/nCD008277-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008277-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/urn:x-wiley:14651858:media:CD008277:CD008277-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_t/tCD008277-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Systolic blood pressure, Outcome 6 Stroke." data-id="CD008277-fig-0008" src="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_n/nCD008277-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Systolic blood pressure, Outcome 6 Stroke.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/references#CD008277-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_n/nCD008277-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008277-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/urn:x-wiley:14651858:media:CD008277:CD008277-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_t/tCD008277-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Systolic blood pressure, Outcome 7 Congestive heart failure." data-id="CD008277-fig-0009" src="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_n/nCD008277-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Systolic blood pressure, Outcome 7 Congestive heart failure.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/references#CD008277-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_n/nCD008277-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008277-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/urn:x-wiley:14651858:media:CD008277:CD008277-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_t/tCD008277-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Systolic blood pressure, Outcome 8 End‐stage renal failure." data-id="CD008277-fig-0010" src="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_n/nCD008277-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Systolic blood pressure, Outcome 8 End‐stage renal failure.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/references#CD008277-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_n/nCD008277-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008277-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/urn:x-wiley:14651858:media:CD008277:CD008277-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_t/tCD008277-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Systolic blood pressure, Outcome 9 All other serious adverse events." data-id="CD008277-fig-0011" src="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_n/nCD008277-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Systolic blood pressure, Outcome 9 All other serious adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/references#CD008277-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_n/nCD008277-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008277-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/urn:x-wiley:14651858:media:CD008277:CD008277-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_t/tCD008277-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Systolic blood pressure, Outcome 10 Systolic blood pressure achieved." data-id="CD008277-fig-0012" src="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_n/nCD008277-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Systolic blood pressure, Outcome 10 Systolic blood pressure achieved.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/references#CD008277-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_n/nCD008277-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008277-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/urn:x-wiley:14651858:media:CD008277:CD008277-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_t/tCD008277-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Systolic blood pressure, Outcome 11 Diastolic blood pressure achieved." data-id="CD008277-fig-0013" src="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_n/nCD008277-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Systolic blood pressure, Outcome 11 Diastolic blood pressure achieved.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/references#CD008277-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_n/nCD008277-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008277-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/urn:x-wiley:14651858:media:CD008277:CD008277-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_t/tCD008277-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Systolic blood pressure, Outcome 13 Number of antihypertensive drugs needed per patient." data-id="CD008277-fig-0014" src="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_n/nCD008277-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 Systolic blood pressure, Outcome 13 Number of antihypertensive drugs needed per patient. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/references#CD008277-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_n/nCD008277-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008277-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/urn:x-wiley:14651858:media:CD008277:CD008277-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_t/tCD008277-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Diastolic blood pressure, Outcome 1 Total mortality." data-id="CD008277-fig-0015" src="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_n/nCD008277-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Diastolic blood pressure, Outcome 1 Total mortality.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/references#CD008277-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_n/nCD008277-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008277-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/urn:x-wiley:14651858:media:CD008277:CD008277-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_t/tCD008277-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Diastolic blood pressure, Outcome 2 Cardiovascular mortality." data-id="CD008277-fig-0016" src="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_n/nCD008277-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Diastolic blood pressure, Outcome 2 Cardiovascular mortality.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/references#CD008277-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_n/nCD008277-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008277-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/urn:x-wiley:14651858:media:CD008277:CD008277-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_t/tCD008277-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Diastolic blood pressure, Outcome 3 Non‐CV mortality." data-id="CD008277-fig-0017" src="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_n/nCD008277-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Diastolic blood pressure, Outcome 3 Non‐CV mortality.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/references#CD008277-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_n/nCD008277-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008277-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/urn:x-wiley:14651858:media:CD008277:CD008277-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_t/tCD008277-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Diastolic blood pressure, Outcome 5 Myocardial infarction." data-id="CD008277-fig-0018" src="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_n/nCD008277-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Diastolic blood pressure, Outcome 5 Myocardial infarction.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/references#CD008277-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_n/nCD008277-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008277-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/urn:x-wiley:14651858:media:CD008277:CD008277-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_t/tCD008277-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Diastolic blood pressure, Outcome 6 Stroke." data-id="CD008277-fig-0019" src="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_n/nCD008277-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 Diastolic blood pressure, Outcome 6 Stroke.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/references#CD008277-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_n/nCD008277-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008277-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/urn:x-wiley:14651858:media:CD008277:CD008277-CMP-002-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_t/tCD008277-CMP-002-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Diastolic blood pressure, Outcome 7 Congestive heart failure." data-id="CD008277-fig-0020" src="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_n/nCD008277-CMP-002-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 Diastolic blood pressure, Outcome 7 Congestive heart failure.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/references#CD008277-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_n/nCD008277-CMP-002-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008277-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/urn:x-wiley:14651858:media:CD008277:CD008277-CMP-002-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_t/tCD008277-CMP-002-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Diastolic blood pressure, Outcome 10 Systolic blood presure achieved." data-id="CD008277-fig-0021" src="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_n/nCD008277-CMP-002-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.10</div> <div class="figure-caption"> <p>Comparison 2 Diastolic blood pressure, Outcome 10 Systolic blood presure achieved.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/references#CD008277-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_n/nCD008277-CMP-002-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008277-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/urn:x-wiley:14651858:media:CD008277:CD008277-CMP-002-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_t/tCD008277-CMP-002-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Diastolic blood pressure, Outcome 11 Diastolic blood pressure achieved." data-id="CD008277-fig-0022" src="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_n/nCD008277-CMP-002-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.11</div> <div class="figure-caption"> <p>Comparison 2 Diastolic blood pressure, Outcome 11 Diastolic blood pressure achieved.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/references#CD008277-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/media/CDSR/CD008277/image_n/nCD008277-CMP-002-11.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD008277-tbl-0001"> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Lower blood pressure (BP) targets compared with standard BP targets for mortality and morbidity</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population: Diabetes Mellitus</b> with elevated blood pressure </p> <p><b>Settings: outpatients</b> </p> <p><b>Intervention: BP &lt; 130/85 mmHg</b> </p> <p><b>Comparison: BP &lt; 140 ‐ 160/90 ‐ 100 mmHg</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Standard BP targets</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Lower BP targets</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Total mortality</b> </p> <p>Systolic targets</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 1.05</b> (0.84 to 1.30) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>4734<br/> (1) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low<sup>4</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>Only one RCT</p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Medium risk population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>60 per 1000<sup>1</sup> </b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>63 per 1000</b> <br/> (50 to 78) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Total mortality</b> </p> <p>Diastolic targets</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Low risk population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 0.73</b> (0.53 to 1.01) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>2580<br/> (4) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low<sup>5</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>High risk of bias</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>30 per 1000<sup>2</sup> </b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>22 per 1000</b> <br/> (16 to 30) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Medium risk population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>60 per 1000<sup>1</sup> </b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>44 per 1000</b> <br/> (32 to 61) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High risk population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>100 per 1000<sup>3</sup> </b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>73 per 1000</b> <br/> (53 to 101) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Total serious adverse events</b> </p> <p>Systolic targets</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 1.01</b> (0.91 to 1.13) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>4734<br/> (1) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low<sup>6</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>Only one RCT</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Medium risk population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>214 per 1000<sup>1</sup> </b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>216 per 1000</b> <br/> (197 to 244) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Based on the event rate in the standard BP target group.<br/> <sup>2</sup>One‐half the medium event rate.<br/> <sup>3</sup>Medium event rate times 1.7.<br/> <sup>4</sup>Only one RCT and confidence intervals includes a 25% increase.<br/> <sup>5</sup>Inadequate sequence generation, no blinding, subgroup analysis and early termination.<br/> <sup>6</sup>Only one RCT and no blinding. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-title"></span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/full#CD008277-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD008277-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Systolic blood pressure</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Total mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Cardiovascular mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Non‐CV mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Total serious adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Myocardial infarction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Stroke <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Congestive heart failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 End‐stage renal failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 All other serious adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Systolic blood pressure achieved <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Diastolic blood pressure achieved <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12 Withdrawals due to adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Number of antihypertensive drugs needed per patient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Systolic blood pressure</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/references#CD008277-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD008277-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Diastolic blood pressure</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Total mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2580</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.53, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Cardiovascular mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2451</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.52, 1.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Non‐CV mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2451</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [0.36, 1.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4 Total serious adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Myocardial infarction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2451</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.64, 1.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Stroke <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2451</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.42, 1.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Congestive heart failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>950</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.58, 1.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8 End‐stage renal failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9 All other serious adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Systolic blood presure achieved <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1079</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.31 [‐8.69, ‐5.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Diastolic blood pressure achieved <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1079</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.85 [‐7.41, ‐6.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12 Withdrawals due to adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13 Number of antihypertensive drugs used per patients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Diastolic blood pressure</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008277.pub2/references#CD008277-tbl-0003">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD008277.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD008277-note-0002">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD008277-note-0004">فارسی</a> </li> <li class="section-language"> <a class="" href="ms#CD008277-note-0001">Bahasa Malaysia</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008277\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008277\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008277\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008277\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008277\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008277\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008277\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008277\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008277\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008277\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008277\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008277\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008277\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008277\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008277\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008277\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008277\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008277\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=zCmos3jT&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008277.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD008277.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD008277.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD008277.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008277.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740725492838"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD008277.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740725492843"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD008277.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e7c93ca3cf4b8',t:'MTc0MDcyNTQ5My4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 